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Section I: Abstract
Background: People experiencing serious illness have significant unmet physical, emotional,
social and spiritual needs. The Quality Oncology Practice Initiative (QOPI) requires patients to
be screened for emotional wellbeing and pain by their second oncology visit. This project details
one cancer center’s quality improvement initiative to (a) implement electronic screening of every
cancer patient by their second oncology visit, (b) design processes for ongoing assessment and
intervention of need(s), and (c) develop measureable and sustainable evaluation metrics to ensure
that palliative care needs are met. Methods: In June 2015, we launched electronic collection of
patient-reported outcomes (PROs) using the Patient Reported Outcome Measurement Instrument
System (PROMIS) global screen. Screening was completed via the health portal or clinic
computer prior to the first return visit and at 30-day intervals. Results: The primary measures of
interest were the percentage of completed PROMIS questionnaires and the percentage of
relevant answers, with a target completion rate of 60%. The highest completion rate was 25.3%.
Six weeks of relevant answers were collated from August 18, 2015 through September 30, 2015
with a range of 3.6% to 5.3% of patients having relevant answers. Conclusions: The utilization
of a screening tool is only the method by which assessment and evaluation of comprehensive
care needs is initiated. Evidence-based practice guidelines and clinical care pathways must also
be in place to manage each symptom identified in a standardized way. Support for oncology
nurses to lead assessment and connect patients with resources is an opportunity to incorporate
primary palliative care into oncology practice.
Keywords: screening, screening tool, emotional wellbeing, patient-reported outcomes
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Section II: Introduction
Approximately 14.5 million people in the United States are living with cancer today. It is
estimated that by January 2024 this number will grow to include 19 million cancer survivors
(American Cancer Society [ACS], 2014). This can be attributed to phenomenal breakthroughs in
cancer research and progressive treatment modalities that lead to longer life expectancies for
patients with cancer. Currently, nearly half of those surviving with cancer are 70 years or older
(ACS, 2014). However, a chasm exists between these extraordinary innovations in treatment and
the longitudinal impact these therapies have on the quality of life (QOL) of patients, including
their relationships with family and friends.
Research indicates that patients with serious illness do not receive adequate symptom
management and have unmet psychosocial needs leading to poor patient and family satisfaction
(Meier, 2011; Wright et al., 2008). There is also literature demonstrating how comprehensive
symptom and emotional well-being correlate with reduced symptom burden, which leads to
enhanced quality of life (Kamal et al., 2013; Von Roenn & Temel, 2011). Furthermore, studies
have revealed that clinicians do not adequately screen for emotional distress, physical, or
psychological needs leaving a major gap in health care for these patients and contributing to
poorer patient outcomes (Brooks et al., 2014; Meier, 2011; Ristevski, Breen, & Regan, 2011).
Thus the question arises, how do oncology healthcare providers more effectively identify cancer
patients in need of palliative care or other supportive services at the right time in their disease
trajectory?
The Institute of Medicine (IOM, 2001) report Improving Palliative Care for Cancer
brought awareness to the role of palliative care as a mechanism toward better management of
complex symptoms and psychosocial issues, and called for improved access to palliative care
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services. Over 10 years later, the American Society of Clinical Oncology (ASCO) published a
provisional clinical opinion (PCO) stating that the combination of standard oncology care with
palliative care leads to better patient and caregiver outcomes. This PCO is supported by seven
published randomized controlled trials (RCTs) validating the feasibility of providing palliative
care concurrent with routine oncology care (Smith et al., 2012). The most significant of these
studies is a phase III RCT conducted by Temel et al. (2010) with patients who have metastatic
non-small-cell lung cancer (NSCLC). The findings of this study revealed an increased QOL
(98.0 vs. 91.5 [high scores indicating better QOL], p = 0.03) and a decrease of depressive
symptoms (16% vs. 38%, p = 0.01) among the study group. A surprising finding was the median
survival rate: patients survived longer in the intervention group (11.6 months vs. 8.9 months, p =
0.02) despite a decrease in the aggressiveness of end-of-life care (33% vs. 54%, p = 0.05).
The second noteworthy RCT was the first study to evaluate the concurrent use of
palliative care with oncology care through a nurse-led intervention. Bakitas et al. (2009)
measured QOL, symptom intensity, mood, and resource use among 322 patients with several
types of advanced cancer using a variety of assessment tools. At baseline, there were no
statistically significant differences between the two groups. Nevertheless, longitudinal intentionto-treat analyses for the total sample revealed higher QOL (p = 0.02) and depressed mood (p =
0.02), but no truly significant decrease in symptom intensity (p = 0.06) for the intervention group
compared to the control group. Despite negative results, Bakitas et al. (2009) were pioneers in
initiating the exploration of various palliative care interventions (for example, the relationship of
education, open communication, family support, and resource navigation and management on
patient and family overall wellbeing) and positive outcomes.
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Palliative care is estimated to save the United States health care system $1.2 billion per
year over current inpatient utilization levels. This savings projection could increase to $4 billion
annually if palliative care capacity expanded to meet the needs of six percent of hospital
discharges at 90% of hospitals (with a minimum of 50 beds) in the United States. Hospice care is
projected to save an average of $2,300 per hospice beneficiary, yielding an overall savings of
more than $3.5 billion a year (Meier, 2011).
To date, there are no studies that have reviewed the cost impact of palliative care on an
outpatient oncology care program. One reasonable explanation may be the complexity of
determining how to capture and assess the true costs of palliative care. There are direct and
indirect costs that are often overlooked, but should be considered when evaluating the cost
effectiveness of palliative medicine. The direct costs include the expenses of medications,
procedures and diagnostic tests, and the salaries of healthcare providers (e.g., RNs, physicians,
social workers, and advanced practice providers). Direct non-healthcare costs include expenses
outside of the walls of Stanford Cancer Institute (SCI). These expenses include in-home
healthcare services, transportation to and from appointments, child-care costs, or assistive
equipment. Indirect costs (e.g. the inability to attend work or school, or carry out activities of
daily living) impact the illness and access to treatment for patients and their caregiver(s)
(Simeons et al., 2010).
Though it is difficult to place a monetary value on improved QOL, studies show that
early referral to hospice and less money spent on futile medical interventions in the last months
of life has resulted in cost savings (Meier, 2011; Wright et al., 2008). Furthermore, a recent study
by Seow et al. (2014) retrospectively reviewed the impact of community-based palliative care in
the province of Canada. Their retrospective cohort study found that patients receiving palliative
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care, across all the palliative care teams in the province, had an overall lower number of
hospitalizations and emergency department visits in the last two weeks of life, and were less
likely to die in the hospital compared to their matched control group receiving usual care (Seow
et al., 2014).
As palliative medicine has continued to evolve, so has the complexity of the care required
by cancer patients (Higginson & Evans, 2010). In a systematic review of 44 studies (involving
25,074 patients), Teunissen et al. (2007) identified 37 symptoms common to more than 10% of
patients. Fatigue, pain, lack of energy, weakness, and loss of appetite were the most common
symptoms reported. Interestingly, the most significant finding, and consequent limitation of this
study, was the inconsistency among symptom assessment methods, which led to varying degrees
of symptom prevalence responses. As a recommendation, Teunissen et al. encourage the
utilization of a standardized comprehensive assessment tool, such as a questionnaire, to further
capture the true essence of symptom burden among these patients. This recommendation along
with ASCO and the National Cancer Care Network (NCCN), collectively advocate for the
integration of palliative care into cancer care (NCCN, 2014; Smith et al., 2012). Furthermore, the
Center to Advance Palliative Care (CAPC), a nationally-recognized organization committed to
palliative care growth and development, recommends the use of a screening tool(s) for
assessment of physical, emotional/psychosocial, medical, or spiritual needs (CAPC, 2011). The
two RCTs by Temel et al. (2010) and Bakitas et al. (2009) operationalize these recommendations
and demonstrate how screening tools can effectively measure and evaluate patient-specific
palliative care needs.
From these recommendations came the impetus for this evidence-based practice change
project: to implement screening for comprehensive care needs of cancer patients from early
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diagnosis and throughout their disease trajectory to increase patient access to supportive care
services, improve symptom management, and enhance QOL. This project encompassed the
implementation of a screening tool and the development of standard processes to ensure patients
had the opportunity to complete the questionnaire so that identified needs could be identified,
addressed, managed, and monitored by the appropriate clinical care team member(s). This
project is still undergoing iterative changes and development however, preliminary analysis
reveals promising results.
Background Knowledge
Description of setting. This evidence-based, change-of-practice project took place at the
Stanford Cancer Institute (SCI), which is a part of Stanford Health Care (SHC) (see Appendix A
for institution’s permission). SHC is a prominent Bay Area and world-renowned institution, and
holds a reputation for excellence in patient care. The institution is highly respected for expertise
in cardiac care, cancer treatment, neurosciences, surgery, and organ transplants. Patients travel
from neighboring cities, distant states, and around the world to receive exceptional general acute
care services and tertiary medical care. This academic teaching institution employs 1,907
hospital medical staff – a combination of full-time faculty and physicians – and houses 1,044
interns and residents. In addition, they have a nursing workforce of over 2,300 registered nurses
(RNs). SHC partners with Stanford University School of Medicine, the oldest school in the
Western United States, to foster excellence in the translation of knowledge into quality and
efficacious patient care (Stanford University, 2014).
Stanford Clinics, a medical group comprised of 493 full-time faculty physicians at the
Stanford School of Medicine, is a division of SHC. Over 100 specialty care services are offered
by Stanford Clinics to a diverse population of patients. The SCI houses several of these specialty
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clinics, providing treatment for 22 different cancer diagnoses. SCI houses a radiation therapy
site, a mammography and diagnostic radiology unit, multimodality cancer clinics, an infusion
treatment area, a learning center, social services, nutritional services, a tumor registry, a
pharmacy, an academic and clinical research site, and a conference center. Treatment is provided
by both physicians and scientists, along with a robust interdisciplinary healthcare team, who
partner together to treat all forms of cancer. The mission of SHC is “to care, to educate, to
discover,” and this mission is integrated into daily clinical and operational activities (Stanford
School of Medicine, 2014a).
SCI has achieved the distinguished designation as a National Cancer Institute and is a
founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 23 of
the world’s leading cancer centers devoted to improving the quality and effectiveness of the care
cancer patients receive. The SCI sees approximately 200 new patients per month. In addition,
they have an average of 1,100 returning SCI visits per month, and a total of 15,700 SCI patient
visits per year. SHC is consistently recognized by U.S. News and World Report as a top hospital
in the nation for cancer care. Other prestigious awards include Magnet status and a certified
Quality Oncology Practice Institute by ASCO (Stanford School of Medicine, 2014a; Stanford
School of Medicine 2014b).
Palliative medicine at SHC. Palliative medicine (PM) is a specialty service comprised
of an interdisciplinary group of clinicians who are devoted to mitigating symptoms that plague
patients with chronic disease and have the expert training in managing the long-term
psychological, social, emotional, physical, and spiritual effects of the disease and its treatment(s)
(Glare et al., 2013; Ristevski, Breen, & Regan, 2011). SHC has had an inpatient PM program
since 2007. This team is comprised of four physicians, four advanced practice nurses, one social
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worker, and one fellow (who rotates through this service every two to four weeks). This team is a
consult service; they receive consult requests from an inpatient referring care team and maintain
contact with the patient and primary team throughout the patient’s hospitalization. They make
recommendations to the primary care team based on their assessment and expertise. If
appropriate, the inpatient PM team will refer the patient to outpatient PM upon discharge.
In 2012 the program’s leadership, recognizing patients’ palliative care needs extend
beyond the acute care setting, expanded to the outpatient setting. The outpatient PM team
consists of three physicians, two advanced practice nurses, three social workers, one chaplain,
and one clinic administrative assistant. This team operates five days a week and also sees
patients based on referrals from a variety of patient care teams. Their goal is to see patients
within one week of referral and on an ongoing basis based on patient need, unless they receive an
urgent same-day referral. Currently, they have over 100 patient encounters per month. Although
the infrastructure is in place, a gap analysis identified several opportunities to improve how
palliative medicine was implemented throughout the organization and advance the delivery of
palliative care.
Gap analysis and identification of care problem. Primary efforts to discover how to
better identify patients in need of palliative care services and how to better provide them these
services began with chart review. Retrospective chart reviews were performed on all patients
from one gynecologic oncology clinic at SCI (n = 120) between June 2014 and February 2015 to
assess whether they were screened via the Patient Reported Outcomes Instrument Measurement
System (PROMIS) for palliative medicine needs at their new patient visit. More specifically,
chart reviews were conducted to identify the percentage of new patients screened, the percentage
of patients who screened positive based on NCCN criteria, and the percentage of patients
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referred to PM (see Appendix B for NCCN Palliative Care Screening Guidelines; see Appendix
C for results from chart review). Fifty percent of the cohort of patients were screened using the
instrument. Less than five percent were referred to PM. However, the chart review revealed that
40% of all patients met NCCN criteria for referral to PM. Referrals to other support services
based on screening included oncology social work and survivorship.
One salient finding from this gap analysis, supported by the literature, recognized that
patients were referred to palliative care late in their disease trajectory or not at all (Hui & Bruera,
2015; Meier, 2011; Temel et al., 2010). Interviews conducted with patients, families, and
oncologists at SCI further revealed that cancer patients were not routinely or comprehensively
screened for palliative medicine needs. Consequently, it was determined a standard process
needed to be employed to capture a broader array of cancer patients to identify palliative care
needs earlier in their cancer journey (see Appendix D for a gap analysis inspired by the Chronic
Care Model; Appendix E for an overview of current state of palliative care at SHC/SCI).
An additional finding from the gap analysis indicated misconceptions and biases from
clinicians and patients alike that palliative care impeded screening, referral, and access to
services. Screening for comprehensive care needs with ongoing assessment and management of
needs is an important component to providing quality patient and family-centered cancer care
(Hui & Bruera, 2015; Kamal et al., 2014). Yet despite its existence for close to a decade, there
continues to be variance in how palliative care is understood and employed both at an
institutional level as well as across the nation and internationally (Glare, 2013; Greer, Jackson,
Meier, & Temel, 2013). Efforts to establish a non-threatening, clear, concise, and compelling
brand for PM at SHC are ongoing in order to dissuade misperceptions and promote greater
access to supportive services for patients and family members. Seventy percent of healthcare
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systems have a palliative medicine program; however, 70% of Americans report they are “not at
all knowledgeable” about palliative care (Parikh, Kirch, Smith, & Temel, 2013, p. 2347).
Fortunately, SHC has embraced the specialty of PM and has assembled a robust
interdisciplinary team of palliative medicine clinicians who provide specialty palliative care
services as well as mentor primary patient care teams in practicing basic palliative care.
Furthermore, it was the request of the SCI leadership team to implement a screening tool and
design a process to identify and manage palliative care needs, allowing for timely project
initiation and eliminating the potential barrier to stakeholder buy-in.
Local Problem
Current models of care at SHC do not routinely incorporate patient and family feedback
into the design, operation, or outcome evaluation into cancer care programs. In addition, SHC
currently has no standardized method of capturing palliative care needs of the cancer patients
they serve. Screening, assessment, and management of needs is fragmented and the process of
making referrals lacks consistency and clarity. Studies have shown that early integration of
palliative medicine into cancer care improves outcomes including quality of life, care
coordination, and survival (Glare et al., 2013; Hui & Bruera, 2015; Kamal et al., 2014). Expert
groups (e.g., American Academy of Hospice and Palliative Medicine, American Society of
Clinical Oncology, Center to Advance Palliative Care, and National Comprehensive Care
Network) recommend early integration of palliative and oncologic care for the best possible
outcomes.
Despite its growing reputation, there is much variability in how palliative care is
understood, utilized, implemented, and measured throughout the U.S. healthcare system (Glare,
2013; Greer et al., 2013), and it is true also for SHC. Through the chart reviews from 120
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patients with gynecological cancers and qualitative information gathered from patients, their
families, and a variety of clinicians, it is apparent that lack of process and ownership of followup, assessment, and management of responses to the PROMIS screening left patient’s needs
largely unacknowledged by the system. While a standardized process for screening is necessary,
resources for assessment and management are also required.
Intended Improvement
It is well documented in the literature that emotional and physical distress in cancer
patients is underreported and undertreated (Wagner et al., 2015). Early identification of palliative
care needs and integration of palliative care services into routine oncology care is essential to
adequately meet the complex care needs of patients and improve quality of life outcomes (Glare
et al., 2013; Parikh et al., 2013; Meier, 2011; Temel et al., 2010). Evidence supports the use of a
screening tool along with clinical care pathways to assist care teams in meeting the
comprehensive care needs of patients in a systematic and standardized way (Chen, Ou, & Hollis,
2013; Carlson et al., 2012; Dudgeon et al., 2012; Bush et al., 2010; Bultz & Groff, 2009;
Khatcheressian et al., 2005; NIH, 2004). Most recently, the Quality Oncology Practice Initiative
(QOPI) requires patients to be screened for emotional wellbeing and pain by their second
oncology visit. This is a standard of care required for accreditation (ASCO, n.d.).
This evidence-based project details the quality improvement initiative to (a) utilize
patient reported outcomes (PRO) screening to identify patient distress and wellbeing, (b) develop
adaptive nurse-led algorithms to assess and intervene for unmet needs, and (c) to provide
standardized clinical care pathways for care and management. Evaluation will initially include
measurement of the number and percentage of screening instruments completed, the number and
percentage with identified needs (termed relevant answers), and the number and percentage of
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patients referred to supportive services, mainly palliative care and social work, as a result of
PROMIS screening. More development is needed for evaluating if patients feel their needs are
met.
Project aim. By December 2015, every new patient with a cancer diagnosis coming to
SCI will be electronically screened using PROMIS by their second oncology visit. The purpose
of this project is to establish an evidence-based process for screening cancer patients for
comprehensive care needs (e.g. physical, social, emotional, and spiritual wellbeing), as well as to
design processes for ongoing assessment and intervention of need(s), and develop measureable
and sustainable evaluation metrics to ensure that palliative care needs are met.
Goals. The primary goal of this project is to implement an electronic screening tool to
identify patient’s supportive care needs with the target of screening all new cancer patients for
distress by their second visit to SCI and every 30 days thereafter. Project performance goals are
to ensure all patients with supportive care needs or relevant answers, as indicated by a response
of fair or poor on the PROMIS tool, are addressed and/or referred to the appropriate supportive
care service(s) in a timely manner. End goals include improvement in symptoms and
psychosocial health, and better resource utilization (e.g. decrease emergency department visits
and inpatient hospital admissions) resulting in significant enhancements to patient wellbeing and
health care cost savings. These goals are supported by the project’s objectives, which are to
increase access to supportive care services in the outpatient setting for patients with a cancer
diagnosis; create an infrastructure for clinicians and patients to ensure routine completion of
PROMIS; and develop a streamlined process for evaluation, follow-up, and monitoring of
identified patient needs.
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Trigger for change: Transformation. The foundation for this evidence-based practice
change project was born out of the Stanford Cancer Initiative, which is a five-year project shared
by Stanford School of Medicine and SHC to develop and implement a new model of cancer care.
This new model combines cutting edge science and technology with an intentional focus on
individual patient-specific needs. The four main areas of influence through Transformation
include creating a new standard of cancer care, targeting the toughest cancers, capturing the
power of cancer science, and seizing innovations. This project is funded by a $125 million
donation by a group of generous donors with the intent to raise another $125 million by the
Stanford School of Medicine (SCI, 2013).
From this initiative and under the Transformation category of “creating a new standard of
cancer care” came the idea to redesign the patient and family experience for the purpose of
building a new palliative care program that is truly centered on patient and families (SCI, 2013).
The ultimate goal of this program is to provide evidence-based medical care that is in alignment
with patient goals and values, and to minimize unwanted or unnecessary medical interventions.
The objectives of this redesign project are the following:
•

to determine the appropriate model of care delivery of PM desired by cancer patients and
their family members/care providers;

•

to determine the best operational means to deliver the optimal model of PM for patients
and their families, again based on patient and caregiver needs;

•

to develop and measure appropriate outcomes for the PM model of care, for providers,
patients, and caregivers (E. Tribett, personal communication, September 11, 2015).
This is a three-year project and is currently in its second year. This specific redesign

project received an additional $500,000 gift from one generous cancer patient and her husband to
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be used only by Dr. Ramchandran for the purposes of creating a better cancer care experience
through better utilization of palliative medicine. This author’s evidence-based practice project is
a component of this larger project to redesign the palliative medicine program at SHC.
Review of the Evidence
Early palliative care. In 2012, the American Society of Clinical Oncology (ASCO)
published a provisional clinical opinion (PCO) stating, when combined with standard oncology
care, palliative care leads to better patient and caregiver outcomes. ASCO openly recognizes this
PCO is not supported by robust data; however, there have been seven published randomized
controlled trials (RCTs) validating the feasibility of providing palliative care alongside routine
oncology care (Smith et al., 2012). In addition to the studies by Temel et al. (2010) and Bakitas
et al. (2009), Greer et al. (2013) published a comprehensive review advocating the integration of
palliative care into oncology care early in the disease process, specifically for patients with
advanced cancer.
Greer et al. (2013) acknowledged the dearth of evidence and limited funding available to
support the delivery and dissemination of palliative care services. Nevertheless, they recognized
the need for attention and the development of clinical guidelines to manage the burdensome side
effects of cancer treatment. The review discussed concurrent models of palliative care delivery in
the outpatient setting as well as provided evidence-based rationales for the early integration of
palliative care into cancer care: high symptom burden for patients with advanced disease,
varying prognostic awareness that results in uninformed treatment decision-making, poor
utilization of resources, late access to end-of-life care, and unnecessarily high treatment costs.
While focus on staging and treatment protocols is important, Greer at al. (2013)
emphasized the need to address the emotional and spiritual distress that accompanies such a
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diagnosis. The recognition of these symptoms often includes some combination of anxiety,
depression, and/or adjustment disorders, and can aid in establishing a strong patient/caregiverprovider relationship. In turn, this relationship leads to greater trust, and decreased psychosocial
distress, with the hope of improving advanced care planning, end-of-life care planning, and
discussing resuscitation preferences earlier on in the disease process.
Palliative care teams also help translate prognostic information into comprehensible
disease awareness, which helps maintain costs. Greater understanding of disease prognosis
improves communication, assists in realistic decision-making throughout the course of the
patient’s illness, and helps allay anxiety and fear. Greer et al. (2013) and Wright et al. (2008)
dispel the myth that conversations about preferences for care (e.g. advance directives) do not
increase depression and worry, rather they decrease feelings of depression, anxiety, and
hopelessness. Greer et al. (2013) summarized the findings of several studies and all agreed on the
need to decrease unnecessary costs (those that are beyond the point of evidence of benefit)
through the implementation of quality metrics to help determine high-quality cancer care across
the spectrum.
The authors also discussed the model of co-management between oncology and palliative
care providers based on pilot feasibility studies and two RCTs. Conclusions support the use of
the integrated or embedded model promoting the comanagement of care: the oncologist directs
cancer-specific treatments and the palliative care team focuses on the physical symptoms and
psychosocial concerns. While there are some limitations to this model (e.g. patients have to have
a higher performance status for outpatient care visits) the potential to improve resource
utilization through complementary comanagement of one’s illness is promising. In this model,
patient symptoms are addressed as they emerge, reducing the likelihood they will seek care in the
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emergency department, as well as reducing the chance they will receive unnecessary procedures
or be admitted to the hospital (Greer et al., 2013).
In their cluster randomized controlled trial, Zimmerman et al. (2014) sought to assess the
impact of early palliative care on various aspects of quality of life. Quality of life was assessed
using the Functional Assessment of Chronic Illness Therapy- Spiritual Wellbeing (FACIT-Sp)
and the quality of life at the end-of-life (QUAL-E). Symptom severity was assessed using the
Edmonton Symptom Assessment System (ESAS), satisfaction with care was assessed using the
family caregiver satisfaction of palliative care services scale (FAMCARE-P16), and problems
with medical interactions was assessed using the Cancer Rehabilitation Evaluation System
Medical Interaction Subscale (CARES-MIS). These assessments were conducted at baseline and
monthly every four months.
Between December 1, 2006 and February 28, 2014, 461 patients from 24 medical
oncology clinics at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada were
cluster randomized to either consultation and follow-up by a palliative care team or to standard
oncology care. These patients had advanced cancer, a European Cooperative Oncology Group
Score (ECOG) of 0-2 (indicating good performance status), and a prognosis of 6-24 months.
Two hundred twenty eight patients were randomized to the intervention group and 233 to the
control group. Those randomized to the interventions group—early introduction of palliative
care—received monthly visits by a palliative care physician and palliative care RN. At every
visit, patients received a structured physical and symptom assessment; discussed goals of care,
support needs, coping and psychosocial distress; and discussed advanced care planning if the
patient was ready and willing. Each patient received a follow-up phone call after every visit by a
palliative care RN and had access to a 24-hour on-call palliative care service.
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Those randomized to the control group received standard oncology care, which consisted
of visits with their oncologist or oncology RN ad hoc, mostly around chemotherapy or radiation
treatment visits. This group did not receive routine assessment of physical, social, emotional, or
spiritual wellbeing nor did they receive any follow-up phone calls unless necessary for logistical
reasons or if receiving a return phone call. This group did have access to a 24-hour oncology
telephone service, staffed by an oncology resident or other oncology clinician. These patients
could also receive a palliative care consult by request (Zimmerman et al., 2014).
There was a significant difference between the control and intervention group on the
QUAL-E (p = 0.05) and FAMCARE-P16 (p = 0.0003) at three months, indicating patients in the
intervention group experienced greater quality of life at the end-of-life and had enhanced family
caregiver satisfaction than those receiving standard care. At four months, patients in the
intervention group had higher scores on the FACIT-Sp, QUAL-E, and FAMCARE-P16,
representing greater quality of life and satisfaction with care. ESAS scores were less than the
control group, indicating better symptom control. There was no significant difference between
scores on the CARES-MIS between groups. Although not without limitations, the findings from
this study favor the integration of palliative care services with standard oncology care in
improving quality of life and satisfaction with care for patients with advanced cancers.
Symptom prevalence. The Institute of Medicine (IOM, 2001) report Improving
Palliative Care for Cancer brought awareness to the role of palliative care as a mechanism
toward better management of complex symptoms and psychosocial issues, and called for
improved access to palliative care services. In accordance with this call to action, Teunissen et al.
(2007) sought to provide insight for clinicians who care for patients with advanced cancer. They
conducted a systematic review evaluating symptom prevalence among a large, heterogeneous
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population of patients with incurable cancer. MEDLINE, EMBASE, and CINAHL were
reviewed and a total of 46 studies met inclusion criteria. The authors divided the studies into two
different groups: Group 1 consisted of 40 studies (25,074 patients) assessing overall symptom
prevalence, and Group 2 contained two studies (2,219 patients) which focused on symptom
burden in the last one to two weeks of life. Each symptom was defined by the authors,
incorporating synonyms, as there was no consistent terminology across studies. Q-tests indicated
a high level of heterogeneity among the studies, one limitation of their review.
Thirty-seven symptoms were identified and found to affect more than 10 % of patients.
‘Fatigue’, ‘pain’, ‘lack of energy’, ‘weakness’, and ‘loss of appetite’ were the most common
symptoms, occurring in more than 50% of patients in Group 1. The most significant finding, and
consequent limitation, was the inconsistency among symptom assessment methods, which led to
varying degrees of symptom prevalence responses. Teunissen et al. (2007) recommend utilizing
a standardized comprehensive assessment tool, such as a questionnaire, to further capture the
true essence of symptom burden among these patients.
Palliative care consultation. Follwell et al. (2009) inadvertently carried out the
recommendation by Bakitas et al. (2009) in their Phase II prospective cohort study by seeking to
discover the value of palliative care consultation on symptom pervasiveness and patient
satisfaction. Over the course of nine months, 150 eligible patients were recruited during their
first visit to the Oncology Palliative Care Clinic (OPCC) at Princess Margaret Hospital in
Toronto, Ontario, Canada. At baseline, patients completed the ESAS and the Family Satisfaction
with Advanced Cancer Care (FAMCARE) scale (Kristjanson, 1993). The primary consultation
lasted 90-120 minutes and included a full history, physical, and psychosocial assessment, from

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  

24

which recommendations for comprehensive supportive care were made on an individual patient
basis.
There was a fairly even distribution of male to female participants (51% vs. 49%,
respectively) with a wide variety of tumor types, and a majority of patients with an Eastern
Cooperative Oncology Group (ECOG) score of 1 or 2. At baseline, the mean ESAS score was
39.5 and the mean baseline FAMCARE score was 34.7. The ESAS score is obtained from the
summation of the individual scores on each of the nine items, with a total range from zero to 90.
The lower the score, the lesser the symptom distress (Zimmerman et al., 2014). The items on the
FAMCARE scale are given on a 5-point Likert scale with one corresponding to very satisfied
and five corresponding to very dissatisfied. The total possible points are 100; thus, the higher the
number the more dissatisfied the individual (Rodriguez, Bayliss, Jaffe, Zickmund, & Sevick,
2010).
Patients were followed up by phone at one week and one month after their initial PC
visit, each time the ESAS and FAMCARE scale were re-administered. At one-week follow-up (n
= 123), there was an overall improvement in the ESAS score by a mean of 8.8 points (P < .0001;
clinical efficacy was evaluated by an improvement in ESAS score by at least one and occurring
in a minimum of 40% of patients for that symptom). There was also demonstrable improvement
in ESAS scores at one month (P < .0001), with significant improvement reported in anxiety,
insomnia, dyspnea, depression, and pain. However, there was a substantial decline in patient
participation (n = 88) introducing the threat of bias into the study, suggesting that the patients
who remained were likely to have better outcomes.
There were also improvements in FAMCARE scores at both one week and one month (P
< .0001 and P = .0002, respectively). More specifically, improvement in the domains of
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information given about how to manage pain, doctor’s attention to symptoms, pain relief, how
thoroughly the doctor assesses symptoms, and speed with which symptoms are treated, were all
found to be statistically significant (P < .0001). These domains represent core values of palliative
care and while it is unrealistic to expect to see relief of every symptom or improvement in each
satisfaction category, these results demonstrate clinically significant outcomes specifically
influenced by palliative care expert intervention (Follwell et al., 2009).
Palliative care assessment tools. In addition to demonstrating the importance of
incorporating palliative care alongside cancer care early on in the disease process, the question of
how to do so remains unanswered. Bausewein, Grice, Simon, and Higginson (2011) conducted a
systematic review to assess how the Palliative Care Outcome Scale (POS) and the Support Team
Assessment Schedule (STAS) have been used, and to identify their respective strengths and
weaknesses. MEDLINE, EMBASE, PsycINFO, British Nursing Index and Archive, and
CINAHL databases were searched, yielding 159 papers, 83 of which were included in the review
(39 on STAS and 43 on POS). The STAS tool was created in 1986 to distinguish the work of
palliative care teams and was designed for use by a provider caring for the patient. The POS
grew out of the STAS 13 years later to incorporate a subjective component, allowing the patient
to rate their physical, emotional, psychosocial, and spiritual symptoms as well as their
information and resource needs.
Each study was evaluated and data aggregated for year of publication, author(s),
location/country, study participants, purpose of chosen outcome measure, data collection
methods, study focus, and results (Bausewein et al., 2011). Findings from this review are
unimpressive and immaterial. Eight STAS studies validated the original version of the tool; four
of the studies used an adapted version. Twenty studies used the STAS in another culture and 19
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papers used the tool in another language. Findings revealed 14 adapted versions of the POS, 12
translations, and 15 studies utilized the tool in languages other than English. While these tools
were intended for use with palliative care patients, various study authors extended both the
STAS and POS for use among patients with HIV/AIDs, neurologic disease, chronic obstructive
pulmonary disorder, congestive heart failure, and chronic kidney disease. Furthermore, these
tools have been implemented in various healthcare settings, among formal and informal
caregivers, translated into several languages, and used around the world (Bausewein et al., 2011).
Although the utilization of these tools has expanded remarkably over the years, there are
more limitations than strengths of this review (Bausewein et al., 2011). There is a significant
threat of bias as the first author developed STAS and POS, and the last author has validated a
translated version of the POS. Secondly, there is poor generalizability of findings as the studies
reviewed were heterogeneous and rigorous statistical analysis was absent. Moreover, there were
no conclusive findings, and observations did not lead to direct implications for practice. This
review further emphasizes the need for standardization of outcome measures and suggests a
universal toolkit of processes and evaluation tools in the provision of care (Bausewein et al.,
2011).
Brasel (2007) introduces several screening tools and discusses the importance of selecting
the tool that will most accurately assess for specific outcome(s) of interest. She reviewed the
Karnofsky Performance Scale (KPS), the Edmonton Symptom Assessment Scale (ESAS), the
Memorial Symptom Assessment Scale (MSAS), the Quality and Quantity of Life Questionnaire,
the Cambridge Palliative Assessment Schedule (CAMPAS-R), and the Palliative Outcome
Surgery Score. Brasel provided a brief description of each tool and explained its application in
practice. While this list is not comprehensive, it highlights the role of each of these screening
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tools in palliative care practice. Furthermore, Brasel reviewed the usefulness of screening tools
as an objective way to estimate prognosis, to reduce the potential for clinician bias to influence
patients and their caregivers when considering patient goals and desire for treatment, and to
assist in monitoring progress and evaluating efficacy of practice.
Although they did not endorse specific assessment tools, the National Institutes of Health
State-of-the-Science panel (NIH, 2004) convened in July 2002 to discuss ways to improve
awareness of cancer-related symptom burden and increase involvement in combating its negative
impact on QOL, particularly addressing pain, depression, and fatigue. This 14-member panel of
oncology, radiology, psychology, nursing, social work, public health, and epidemiology
concluded that routine screenings using brief assessment tools should be employed to better
provide evidence-based care. Furthermore, the panel advocated for these assessment measures to
serve as catalysts for initial and ongoing discussions throughout the course of the illness. Lastly,
they recommended visual analog scale (VAS) or numeric rating scales to be the framework for
these chosen assessment tools.
Richards et al. (2011) observed a gap in assessment of palliative care needs and care
directed towards these needs in the ED. As a solution to help cancer patients better communicate
their complex palliative care needs to ED providers, and in hopes of facilitating care according to
specific need(s), 12 ED clinicians developed and implemented a multidimensional palliative care
assessment tool for cancer patients who present to the ED, Screening for Palliative Care Needs in
the ED (SPEED). Each of these clinicians had training in Education in Palliative and End-OfLife (EOL) Care (EPEC). Each question on the SPEED instrument was individually matched to
similar questions on other validated screening tools, totaling 3,011 questions from 86 identified
symptom assessment tools. Their aim was to evaluate the validity and reliability of this screening
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tool against these other standardized assessment tools. After extensive analysis, the SPEED tool
was found to be effective and valid in screening for palliative care needs in the ED.
Browner and Smith (2013) sought to identify gerocentric assessment tool metrics to
capture the true complexity of cancer needs in the elderly population. They recognized it is not
only crucial to intervene when symptom burden is present, but it is imperative to consider the
spectrum of palliative care needs in the elderly. They briefly discussed the span of symptoms
known to plague geriatric patients, such as neuropathic pain, depression, and diminished physical
functioning. The five screening tools they highlighted were the Memorial Symptom Assessment
Scale (MSAS), the Condensed Memorial Symptom Assessment Scale (MSAS-C), the Edmonton
Symptom Assessment Scale (ESAS), the MD Anderson Symptom Inventory (MDASI), and the
European Organization for Research and Treatment of Cancer’s Quality of Life Core
Questionnaire (EORTC QLQ-C30). In their practice, Browner and Smith use a Rounding Tool
that stems from the MSAS-C that asks two questions specific to the reported symptom. With the
implementation of this particular tool, they have demonstrated a reduction of symptoms in a
cohort of patients. They concluded that while there are several validated and useful screenings,
not one is explicit to the elderly population, nor is one all-inclusive. Browner and Smith further
highlighted that many of the interventions used to treat younger patients are also effective in the
elderly.
Is one screening tool better than another? Many of the reviewed articles sought to
explore whether one screening tool outweighed another. Stro¨mgren, Groenvold, Pedersen,
Olsen, and Sjogren (2002) recognized the array of symptoms cancer patients experience and the
inability of one tool to accurately capture them all. The aim of their retrospective study was to (a)
identify the most common symptoms that warranted a palliative medicine referral, and (b)
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compare their findings with five validated and widely used questionnaires. The five tools
evaluated included EORTC QLQ-C30, the ESAS, the Palliative Care Outcome Scale (POS), the
McGill Quality of Life Questionnaire (MQOL), and MSAS. From their inclusion and exclusion
criteria, these authors identified 171 eligible inpatient adults. They did a chart review to identify
individual patient’s primary symptom(s) or problem(s). Stro¨mgren et al. used the symptoms list
from the EORTC QLQ-C30 and the ESAS to build their symptom inventory. They found 63
problems/symptoms of which 35 were identified by one of the five comparative questionnaires.
Additionally, these authors found that the EORTC QLQ-C30 and the ESAS collectively covered
12 of the most commonly identified problems in the medical record, concluding the EORTC
QLQ-C30 to be the better comprehensive screening tool because it is more generalizable to
different cancer populations and used validated psychometric properties,
In their prospective, cross-sectional study, Schultheis, Hofheinz, Gencer, Blunk, and
Benrath (2013) set out to determine how to best evaluate QOL among patients undergoing
chemotherapy for a gastrointestinal (GI) malignancy. They employed the EORTC QLQ-C30,
Beck depression inventory (BDI), and the VAS for assessment of pain in 150 patients. Low
scores on the BDI and VAS were predictive of poor results in nearly all areas on the EORTC
QLQ-C30 (indicating poor quality of life). Like Stro¨mgren et al. (2002), these authors also
found the EORTC QLQ-C30 adequately incorporated the assessment of pain and depression, and
could be considered as a single all-inclusive assessment tool. An additional advantage identified
was its ability to be converted to an electronic version and distributed via the Internet or on handheld devices (Schultheis et al., 2013).
Pelayo-Alvarez, Perez-Hoyos, and Agra-Varela (2013) also conducted a comparative
study between the POS, Brief Pain Index (BPI), and Rotterdam Symptom Checklist (RSCL) to
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evaluate the reliability and criterion validity of the POS as the concurrent validity among similar
domains in the RSCL and BPI. Analytical findings indicated concurrent validity of the POS only
with the physical domain on the RCSL. However, the pain domain on the BPI is interchangeable
with the pain and physical domains of the RCSL. Nevertheless, these tools are not
interchangeable and the POS cannot be substituted with the BPI or RCSL and obtain the same
outcome measures (Pelayo-Alvarez et al., 2013).
Bush et al. (2010) also advocate for a standardized way to assess QOL in cancer patients,
yet recognize the difficulty in accomplishing this given the large and varying symptoms
experienced. Thus, the authors conducted a retrospective study to explore the relationship
between the single-item ESAS and the multidimensional Functional Assessment of Cancer
Therapy-General (FACT-G), specifically the “feeling of well being” (ESAS WB), and family
well being (FWB), but did not include the social well being (SWB) domain. No conclusive
statements or implications for practice were recommended. Interestingly, the authors divulged
that they use the Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) and the
Functional Assessment of Anorexia/Cachexia Treatment (FAACT) in their daily practices (Bush
et al., 2010).
Screening for distress. In a randomized control trial, Carlson, Waller, Groff, Zhong,
and Bultz (2012) screened all eligible patients through kiosks located in the clinic, then
randomized patients to receive either computer-based triage or personalized triage. The
computer-based triage group was the control group. Once patients completed their screening at
the kiosk, a report was generated, printed, and recommended services were outlined based on the
patient-specific responses. Services included psychosocial support, resource counseling, pain,
fatigue, and nutrition management services. The patients then determined if they would benefit
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from any one or more of the services, and thus would self-refer.
The personalized triage group participants would also complete their screening at the
kiosk and receive a printed report however, they would be contacted via a telephone call by a
psychosocial healthcare professional within three days of completing the screening. The
healthcare professional would then review the same options given to the computerized triage
group, and put in a referral(s) based on the professional’s clinical judgment. A total of 3,133
patients provided baseline data with 1,709 patients remaining at the end of 12 months. Follow-up
was made via phone or email at three, six, and 12 months after initial screening (Carlson et al.,
2012).
The primary objective of this study was to evaluate whether there were any changes
between groups in regards to distress, anxiety, depression, pain, and/or fatigue over the course of
the 12-month study period (Carlson et al., 2012). Surprisingly, the authors did not observe any
differences between groups; both groups experienced decreases in each of the five categories. An
interesting distinction was seen in the group who received personalized triage: this group
accessed more services than the computerized group (1,213 services versus 825 services).
However, all patients who used services demonstrated greater improvement of symptoms
overtime, but were more anxious, depressed, and had more distress at baseline (Carlson et al.,
2012).
This study demonstrates the efficacy of the provision of resources on improving
outcomes in addition to screening (Carlson et al., 2012). The ultimate takeaway from this study
is the importance of comprehensive assessment and management of symptoms once they are
identified through screening to achieve the most positive outcomes and provide the most benefit
to the patient. The authors suggest that personalized triage may provide greater benefit to
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patients with high anxiety and depression as these patients were more likely to use the available
services. Nevertheless, both methods of triage were effective in managing symptoms (Carlson et
al., 2012).
Also recognizing the importance of screening patients for palliative care needs, Paul
Glare and his colleagues (2013) conducted a pilot study among patients with gastrointestinal (GI)
malignancies to evaluate whether the NCCN Guidelines for Palliative Care were feasible to use
for screening and generating palliative care (PC) referrals. Nurses screened all patients who were
admitted to the 16th floor of Memorial Hospital of Memorial Sloan-Kettering Cancer Center
between November 2010 and January 2011. All patients were screened for the presence of the
six following PC concerns: uncontrolled symptoms, moderate-to-severe distress, serious
comorbid illness, a poor prognosis, patient/family concerns about the course of the disease and
the treatment decision-making, and patient/family requests for PC. A positive screening was
defined as any patient meeting one or more of the clinical situations mentioned above. The GI
Oncology service was broken into two teams for the purposes of this project, Team A and Team
B. The NCCN PC Guidelines’ referral criteria were only applied to Team A; if a patient met one
of the 24 referral criteria, the physician would place a PC consult. Any patient on Team B could
receive a PC consult, but this was ordered ad hoc by the physician based on his/her clinical
judgment (Glare et al., 2013).
Over the course of the three-month project, 90% of patients were screened (n = 254).
Seventy three percent of patients on Team A (n = 229) had positive screenings, 87 from Team A
and 83 from Team B; there were no significant characteristic differences between Team A and
Team B. Uncontrolled symptoms was the most commonly reported problem, followed by serious
comorbid disease and a poor prognosis. Fifteen percent of patients reported distress related to
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their cancer diagnosis or its treatment and decision-making concerns. Sixty four percent of
patients on Team A met referral criteria; the median number of positive referral criteria met per
patient was 1.5 (range, 1-11). Sixty- two out of 229 patients (27%) received PC consultations as
a result of this study, 47 from Team A and 15 from Team B (p < .0001). This indicates a
significant increase in access to PC. An additional finding of this study was that these referrals
occurred earlier in the course of disease for patients on Team A (Glare et al., 2013).
Sixteen nurses were surveyed for their feedback and a majority of the respondents found
the screening to be simple and quick and did not significantly impact their workload (Glare et al.,
2013). However, several respondents reported they did not feel screening notably improved
patient care, and furthermore, they did not feel they knew the patient well enough to screen them
accurately. An additional component of this study was the development of a matrix to identify
the complexity of PC needs and indicate whether they could be managed by the patient’s
oncology team (primary or generalist level palliative care) or whether they require management
by a specialist PC team. Thirty percent of patients were identified to have PC needs that could be
addressed and managed by their oncology team, at the generalist level (Glare et al., 2013).
Through this study, Glare and colleagues (2013) demonstrated how screening for distress
helps identify PC needs earlier and is an important component of cancer care, regardless of
disease stage. Fifty percent of patients with early stage disease or no disease screened positive
due to comorbid illness, poor performance status, and/or had uncontrolled symptoms. While this
study has many limitations, it remains one of the few studies conducted evaluating the role of
screening in improving access to PC services. In addition, it highlights the need for more
palliative care education for primary oncology team clinicians (Glare et al., 2013).
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The role of screening tools in measuring outcomes. Dudgeon et al. (2008) conducted
an evaluation study in which they employed a variety of interventions and conducted pre- and
post-study surveys to determine how the practice changes implemented affected the management
of symptoms in cancer patients, caregiver burden, and overall satisfaction of care. The practice
changes developed for the purpose of this study involved an extensive multidisciplinary care
team and consisted of using standardized screening tools, consensus-based collaborative care
plans (CCPs), and guidelines for symptom management to improve responsiveness of the system
to meet patient and caregiver needs. Outcome measures included the number of emergency
department (ED) visits; inpatient hospital admissions; hospital lengths of stay; number of
referrals to both outpatient and inpatient palliative care programs; and time enrolled in a home,
long-term care facility, and palliative care units until death (Dudgeon et al., 2008).
The ESAS tool was administered to eligible patients in November 2002 and November
2003. The Family Satisfaction with Advanced Cancer Care (FAMCARE) instrument was used to
measure caregiver and patient satisfaction with palliative care, and was administered in
November 2002 and November 2003. Lastly, the caregiver reaction assessment (CRA), which
assesses caregiver burden, was administered to caregivers in November 2002 and November
2003 (Dudgeon et al., 2008).
A chart review of two cohorts of participants, both including patients and caregivers, was
used for data analysis and evaluation of interventions (Dudgeon et al., 2008). The findings
demonstrated an improvement in symptom documentation, most significantly in pain
documentation (p <.001), and a decrease in all mean symptom scores on the ESAS (indicating
improvement) except for depression. These findings, however, were not deemed statistically
significant (p = 0.121- 0.914), but could still be considered clinically significant (Dudgeon et al.,
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2008). There was no significant improvement in satisfaction related to care among caregivers or
patients, nor was there a difference in caregiver burden between 2002 and 2003. Administrative
outcomes revealed a reduction in the number of visits made to the ED, fewer inpatient hospital
admissions, and a decrease in deaths in the acute care setting (Dudgeon et al., 2008).
The acknowledgment of invasive symptom prevalence among cancer patients initiated a
discussion about what to do when symptoms are identified (Browner & Smith, 2013). Seow,
Sussman, Martelli-Reid, Pond, and Bainbridge (2010) examined whether patients who reported
greater symptom burden, indicated by higher scores on symptom assessment measures, received
superior symptom-specific intervention. To evaluate symptoms, the authors used an electronic
form of the ESAS and conducted retrospective chart reviews of 912 breast and lung cancer
patient visits noting documentation of symptom(s) and whether action was taken to address the
identified symptom(s) within one week. The primary independent variables were pain and
shortness of breath (SOB) and the outcome measure was action taken related to either symptom
whether it was drug therapy, a referral, a test, or other treatment. Scores were categorized as
none (0), mild (1-3), moderate (4-6), or severe (7-10).
Seow et al. (2010) found a greater correlation between severe-reported symptoms and
documentation (48% for pain and 79% for SOB). However, this did not consistently correlate to
enhanced documentation of actions taken related to the symptom; yet as the severity of
symptoms worsened, clinicians were more likely to document the symptom and take action. The
authors discussed the advantages and disadvantages of the use of a screening tool and recognized
that it does not always lead to improved symptom management, but they believed it facilitated
discussion of treatment plans and provided a consistent unit of measure for symptom monitoring.
The findings also suggested more attention is needed to create clear clinical care pathways for
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symptom intervention to better alleviate symptoms and lead to improved patient outcomes.
Kamal et al. (2013) pioneered their own electronic assessment tool, the Quality Data
Collection Tool for Palliative Care (QDACT-PC), which measured the relationship between
assessment of symptoms and patient outcomes. In this cross-sectional analysis they compiled 18
metrics taken from ASCO’s Quality Oncology Practice Initiatives (QOPI); the Cancer Assessing
Symptoms, Side Effects, and Indications of Supportive Treatment (ASSIST); and the Carolinas
Center for Medical Excellence in Hospice: Prepare, Embrace, Attend, Communicate, and
Empower (PEACE) project. Conformance was measured for each metric across 459 cancer
patients. Assessment of comprehensive symptoms, including constipation and fatigue, and the
timely management of reported symptoms were all highly positively correlated to greater QOL
(p < .05) and emotional wellbeing (p = .001).
Additionally, a high performance status (measured by the Palliative Performance Scale
[PPS]) was also predictive of high QOL ([OR], 5.21; P = .003). Though not without limitations,
this study illustrates how to test conformance among quality measures and evaluate patient
outcomes. While it does show 100% positive correlation of evaluable measures with QOL, this
study does demonstrate the utilization of a screening tool to assist in more fully understanding
patient needs and how interventions positively influence patient outcomes, specifically QOL.
Kamal et al. (2013) also advocate for the development of care pathways to assist in standardizing
palliative care to address specific needs and ultimately improve patient outcomes.
The influence of screening tools on clinical care pathways. Khatcheressian et al.
(2005) advocate for better recognition of symptoms in cancer patients and the implementation of
algorithms or clinical care pathways that will adequately address and monitor for change. These
authors review the state of palliative care practice and serve as a resource for practical ways to
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integrate the control of symptoms into patient care. The authors (who are palliative care experts
from the Palliative Leadership Center) endorse both the ESAS and RSCL as appropriate
symptom assessment measurements. The paper reviewed various studies that demonstrate
improved outcomes in pain using pain assessment scales and algorithms as an example for the
utility of assessment scales in practice. Furthermore, the correlation among improved symptom
control and lower healthcare costs was examined. This paper also highlights the standard set
forth by the Center to Advance Palliative Care (CAPC) that utilization of standardized, feasible,
reliable, and valid assessment tools should be incorporated into daily practice. Additionally,
Khatcheressian et al. briefly discuss how electronic triggers have the potential to aid physicians
in improving palliative care assessments and more successfully integrating evidence-based
practice guidelines into palliative care practice.
Cleeland et al. (2013) recognized that the purpose of symptom identification extends
beyond palliation and serves to provide significant information to help clinicians deliver better
cancer-specific care. For example, as a result of documented patient symptomology,
pharmaceutical companies can better understand and potentially tailor drug therapy to the side
effect profile identified through symptom assessment. This scenario speaks to the role of
symptom analysis in clinical research, yet still does not address the lack of standardization of
symptom measurement. In response to this gap, a group of interprofessionals from the Food and
Drug Administration, National Cancer Institutes, pharmaceutical companies, researchers, and
patient advocates convened to form a taskforce, Assessing the Symptoms of Cancer using
Patient-Reported Outcomes (ASCPRO) (Cleeland et al., 2013).
The purpose of this taskforce was to review the current state of symptom measures in
clinical research and make recommendations for improved utilization and implementation
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(Cleeland et al., 2013). While they did not discuss specific measurement tests like Brasel (2007),
they emphasized the need to assess multiple symptoms in an appropriate, valid, and reliable way.
They also encouraged assessment on a case-by-case basis ensuring adequate and thorough
assessment of symptoms that will reveal meaningful and useful information (Cleeland et al.,
2013; see Appendix F for an evidence table of the RCTs included in this literature review; see
Appendix G for a breakdown of levels of evidence of all the articles reviewed in this section).
Clinical Implications
In an attempt to operationalize and heed the recommendation from ASCO (Smith et al.,
2012) and the NCCN (n.d.) to incorporate palliative care alongside cancer care early in the
disease process, the articles reviewed have uncovered a common discrepancy: a lack of
standardization of tools to assess the impact of palliative care and evaluate outcomes in an
organized way. Furthermore, a resounding endorsement for a specific symptom assessment tool
to use is lacking despite the significant body of evidence supporting the value of screening tools
in palliative care practice. A majority of the articles recommend similar characteristics such tools
should possess.
Focusing on screening tools specific to emotional distress, Vodermaier, Linden, and Siu
(2009) discuss general principles for the selection and application of such tools. The
recommendation is for shorter-length tools for patients in the hospital or patients who are
undergoing treatment. This is for the purpose of conserving patient energy as well as considers
the feasibility of using a longer assessment tool in the acute care setting. On the other hand, they
recommend a longer screening tool be administered to patients post-treatment or in the outpatient
setting as these tools tend to more comprehensively capture patient needs. They advised for the
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consideration of psychometric properties and encouraged tool length, treatment setting, and
patient disease stage to ensure an appropriate tool selection (Vodermaier et al., 2009).
Advantages and disadvantages of screening tools. The following advantages were
highlighted by various authors included in this review. Screening tools:
•

allow for objective evaluation by the patient, family, and provider and highlight symptom
control (Cleeland et al., 2013; Kamal et al., 2013; Brasel, 2007);

•

aid in facilitating open discussion about met and unmet goals, as well as treatment plans
and expectations (Schultheis et al., 2013; Bush et al., 2010);

•

help predict prognosis and survival (Brasel, 2007);

•

can be integrated into the electronic medical record and distributed via hand-held devices
or touch screens (Schultheis et al., 2013; Seow et al., 2010);

•

can improve symptom documentation (Seow et al., 2010; Dudgeon et al., 2008);

•

foster better individual patient symptom assessment and individualized treatment
(Cleeland et al., 2013; Kamal et al., 2013; Schultheis et al., 2013; Richards et al., 2011;
Bush et al., 2010; Seow et al., 2010);

•

provide a standard way in which to initially assess and monitor symptoms throughout the
course of the cancer care trajectory (Pelayo-Alvarez et al., 2013; Schultheis et al., 2013;
Bush et al., 2010; Vodermaier et al., 2009; Dudgeon et al., 2008; Katcheressian et al.,
2007; NIH, 2004; Stro¨mgren et al., 2002);

•

assist in early detection of symptoms and more quickly detect changes as they occur
(Bush et al., 2010);

•

help prioritize patient services and resources based on symptom prevalence and severity
(Carlson et al., 2012).
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The review also highlights the disadvantages of screening tools. The disadvantages include
the following:
•

those who are sicker may not be able to use assessment tools and the lower response rates
from this patient population skews information about these particular patient needs (NIH,
2004; Stro¨mgren et al., 2002; Hearn & Higginson, 1999);

•

no tool is completely comprehensive, thus there is the chance for certain symptoms not to
be offered or addressed (Bourbonnais, Perreault, & Bouvette, 2004).

Theoretical/Conceptual Framework
Given that cancer is now considered a chronic disease (Centers for Disease Control and
Prevention [CDC], 2014), it seems appropriate and perhaps innovative to employ the wellknown, well-published, and widely implemented Chronic Care Model as the conceptual
framework for this project (McLellan et al., 2014; Tu et al., 2013; Coleman, Austin, Brach, &
Wagner, 2009; Hung et al., 2007; Wasson, Godfrey, Nelson, Johnson & Batalden, 2007;
Parchman, Zeber, Romero, & Pugh, 2007; Vargas et al., 2007; Homer et al., 2005; Bodenheimer,
Wagner, & Grumbach, 2002). This model attributes its success in high-quality chronic disease
management to ensuring a comprehensive interwoven system is in place to address and
anticipate the plethora of needs that accompany a chronic illness. In order to best satisfy these
needs, Dr. Wagner and colleagues from the MaColl Center for Healthcare Innovation identified
six elements crucial to the successful delivery of chronic disease care: health system, delivery
system design, decision support, clinical information systems, self-management support, and the
community. Together, these elements make up the chronic care model (Improving Chronic
Illness Care [ICIC], 2014).
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The elements of primary focus for the purposes of this project are delivery system design,
decision support, and self-management support, although there will be some attention paid to
clinical information systems. The health system element—which focuses on the importance of
gaining recognition, permission, and support from key stakeholders for program success and
sustainability—was fortunately established prior to starting this project and was, in fact, the
catalyst for the development of this project. The community element emphasizes the importance
of partnering with outside organizations for long-term disease control (ICIC, 2014). While a vital
strategic component of this model, this element is outside of the scope of this project.
The delivery system design element of the Chronic Care Model is at the core of this
project as it is within this element that the project is operationalized. This element distinguishes
the significance of effective and efficient patient-centered coordinated care, which the review of
the literature indicates is lacking in the provision of cancer care, and therefore delivery system
design embodies the primary goal of this project. In addition, this element aligns well the
integrated care model, a framework that encourages direct collaboration between the primary
oncologist and the palliative care team at the point of diagnosis (Bruera & Hui, 2012). Through
decision support, applying evidence-based clinical guidelines into daily practice, and selfmanagement support that empowers patients to take ownership of their health and wellbeing,
cancer patients can receive appropriate individualized care (ICIC, 2014).
While many institutions and organizations are working to provide symptom assessment
and psychosocial distress screening earlier for patients diagnosed with cancer, there remains a
question on how best to do this. Many experts recommend an integrated model of palliative care
provided concurrently with standard oncology care (Greer et al., 2013; Hui & Bruera, 2013;
Smith et al., 2012; Edgren, 2008). In the few studies that have measured outcomes when
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palliative care is integrated into oncology care, findings reveal these patients to have greater
satisfaction, improved quality of life, and better mood (Zimmerman, Swami, & Krzyzanowska,
2014; Temel et al., 2010; Follwell et al., 2009).
Integration of palliative care into cancer care can take many forms depending on the
setting, clinical practice, and infrastructure. This quality improvement project aligns with what
Hui and Bruera (2013) identify as the provider-based model, which empowers oncologists to
provide primary palliative care to their patients, to the extent of their clinical expertise, comfort,
and bandwidth. Patients with more complex or severe needs are then referred to secondary
palliative care, which consists of specialty palliative care clinicians who meet with patients
separate from their oncologists and support them physically, emotionally, psychosocially, and/or
spiritually for as long as necessary. Tertiary palliative care refers to the provision of palliative
care by an inpatient palliative care team who provides support and care for patients with complex
needs who are hospitalized. This model leaves the provision of both primary and secondary
palliative care to the discretion of the primary oncology team, leaving much variability in the
referral, utilization, and subsequent need for secondary and tertiary palliative care (Hui &
Bruera, 2013).
The future state of this quality improvement project will incorporate aspects of the
systems-based model (Hui & Bruera, 2013). In this model, there is a standard set of criteria
patients must meet to receive a referral for palliative care services. This is in effort to streamline
the referral process in order to provide every patient with the same opportunity to access these
services, and thus not be dependent on an oncologist. In the next phase of this project, the hope is
to alert the clinicians to relevant answers when they open the patient’s chart, as well as to
automate referrals to supportive care services based on PROMIS questionnaire responses.
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Currently, RNs, advanced practice providers (APPs), and physicians can identify if patients have
relevant answers by a red exclamation mark next to the questionnaire, but they need to access
the questionnaire in order to see this. The goal of integration, no matter the model, is to optimize
patient access to supportive care and to enhance the quality of life of both patients and caregivers
through enhanced coordination of care among healthcare providers and the provision of timely
access to supportive care and resources.
Section III: Methods
Ethical Issues
This project was deemed an evidence-based practice quality improvement project by the
University of San Francisco Doctor of Nursing Practice faculty, and thus exempt from the
Institutional Review Board for the Protection of Human Subjects (Appendix H). No identifying
patient information was used and all rules and regulations identified by the Health Insurance
Portability and Accountability Act (HIPAA) were upheld. Each team member involved went
through an online module about patient confidentiality and HIPAA developed by SHC.
Ethical principles. This project serves to promote the ethical principles of beneficence,
respect for autonomy, and to a certain degree, justice. At the heart of this project is the desire to
do what is good (beneficence) for every patient with cancer who walks through the doors of SCI.
This sentiment is operationalized through screening for distressing symptoms and psychosocial
needs. If providers can more readily identify patients’ needs early on in their diagnosis, then they
can provide the patients with resources, improve their quality of life, and better support them
throughout their cancer care trajectory. As much of the literature supports, cancer care is more
than just treatment of the disease; it is whole person care and encompasses care for the physical,
spiritual, psychosocial, and emotional domains (Greer et al., 2013; IOM, 2008; Jacobsen &
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Wagner, 212; Meier, 2011; Ristevski et al., 2011; Smith et al., 2012). Furthermore, screening for
comprehensive care needs allows providers to individualize care and maximize beneficence for
each patient (Rainbow, 2002).
This project also upholds the principle of autonomy by facilitating patient empowerment.
With screening comes improved identification of needs, which leads to more personalized
discussions about how best to meet patients’ needs with respect to their goals and values.
Providing whole-person care allows for the patient to choose what resources/services/treatment
modalities work best for them and most positively contribute to their quality of life. Patients also
have the choice not to complete the screening, also respecting patient autonomy (Rainbow,
2002).
Lastly, the principle of justice is illuminated by this project as screening all cancer
patients—regardless of their cancer diagnosis, age, demographic, or socioeconomic status—
ensures equal opportunity for all cancer patients to participate and potentially benefit from better
need identification and management. Subsequently, access to supportive care services is
available to all patients, not just those who complete screening; however, those who complete
screening are more likely to gain earlier access to these services. Nevertheless, this project casts
a net wide in the hope of reaching all patients and improving their quality of life through early
identification of needs and improved management of those needs (Rainbow, 2002).
Planning the Intervention
The intervention. The findings of an extensive gap analysis, the results from small tests
of change and pilot projects, and responding to QOPI’s accreditation guidelines requiring
screening cancer patients for distress and wellbeing solidified SCI’s commitment to this
evidence-based practice quality improvement project. At the foundation of this project lies the
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primary intervention: the implementation of an electronic screening tool to assess for
comprehensive cancer patient needs. The PROMIS global screen was the assessment tool chosen
for use SCI-center wide. The planning for this project took place in three phases.
Phase one: Selecting a screening tool. In the fall of 2013, Dr. Kavitha Ramchandran, a
thoracic oncologist and Director of Outpatient Palliative Medicine at SHC, was approached by
the Vice President and Director of SCI Operations and asked to select a screening tool that could
be used to screen patients for palliative care needs throughout their cancer care experience. Dr.
Ramchandran then asked this author—a doctoral student who is a seasoned
hematology/oncology nurse with a passion for palliative care—to partner with her to fulfill this
request. This author conducted a review of the literature to determine if one standardized,
validated, comprehensive screening tool existed for the purpose of assessing palliative care
specific needs (e.g., physical, social, emotional, and spiritual wellbeing).
The search concluded there was no one tool that was recommended over another;
however, five tools were identified as being most popular for use among palliative care patients:
the European Organization for Research and Treatment of Cancer’s Quality of Life Core
Questionnaire (EORTC QLQ-C30); the Edmonton Symptom Assessment Scale (ESAS); the
Memorial Symptom Assessment Scale (MSAS); the Palliative Care Outcome Scale (POS); and
the Rotterdam Symptom Checklist (RSCL). Although each of these tools has been employed in
the palliative care setting, the POS is the only tool that was originally designed and implemented
specifically for use in palliative care.
Without any true analysis, the POS was chosen for its broad assessment of symptoms
including physical, psychological, emotional, and spiritual symptoms, as well as information and
support needs. The POS is a validated instrument that was developed in 1999 and has been used
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in a variety of settings: home, hospital, hospice, or nursing home (Bausewein, Daveson, Benalia,
Simon, & Higginson, n.d.). It is a ten-item measurement tool and is informally endorsed by
Center to Advance Palliative Care (CAPC). The overall profile score is the sum of the scores
from each of the ten questions; therefore, the overall profile score can range from zero to 40. The
total POS score is useful in understanding the broad picture, whereas individual scores such as
pain and depression can also give important information on key aspects of the patient’s situation
(Bausewein et al., n.d.).
Dr. Ramchandran and this author initially piloted the POS in the Gynecologic Oncology
outpatient clinic with one RN over 90 days between June 2014 and September 2014. Screening
with the POS was done by a Multidisciplinary Care Coordinator (MCC), an RN whose job
responsibilities include initial intake of patients over the phone, helping patients and families
navigate through the Stanford healthcare system, and assisting them when they make subsequent
visits to the clinic. The POS screen was done by phone, prior to the patient’s first visit with their
treatment team. A process document was designed by Dr. Ramchandran and a palliative
medicine (PM) social work colleague to assist the nurse in sounding more natural in
administering the screening while maintaining standardization of the screening process across all
patients.
Beyond the initial training, workshops were conducted utilizing role-play methods as
well as literature on therapeutic communication. Participants in the workshops were from
different disciplines including a palliative medicine physician, a master’s-prepared nurse that
specializes in palliative medicine, an MBA-prepared hospital administrator, two bachelor’sprepared oncology nurses, this author, and a member of the Stanford Cancer Institute Patient and
Family Advisory Council.
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To complete the screening, the MCC followed a written script for the POS, tallied the
score, and made a referral to palliative medicine based on a score of > 20. Dr. Ramchandran and
this author compared the POS to the NCCN criteria for referral to palliative medicine. Patients
were considered positive on the palliative care screen based on a score of 20/40 on the POS, a
positive score on any one of the seven palliative care domains as designated by the NCCN
guidelines (uncontrolled symptoms, moderate to severe distress, serious comorbid physical or
psycho-social condition, life expectancy < 6 months, metastatic solid tumors, patient family
concerns about decision making or course of care, and patient/ family requests for palliative
care) (NCCN, n.d.)
Thirty-six patients were screened by the MCC. Thirty-three out of 36 completed the POS
successfully during the initial intake call. Based on the screening criteria of a score of 20/40 on
the POS, no patients met the criteria for referral to palliative care. Based on the NCCN criteria
applied broadly (a positive for any single domain of the seven) 18 patients met the criteria.
Ultimately two patients were referred to palliative care based on the clinical judgment of the
MCC.
The primary challenges in the utilization of the POS were its administration over the
phone and the timing of administration, which was early in the patient’s relationship with the
MCC. Based on feedback received from the MCC, it was difficult for her to deliver the screening
in a natural way without losing the language and content of the screening. An additional
significant barrier was the scoring system as no patients were screened into PM, leaving much of
these decisions up to the MCC’s clinical judgment and missing patients who would have
benefited from PM early in the care continuum.
Based on the small pilot study in the Gynecologic Oncology clinic, Dr. Ramchandran and
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the director of the survivorship program at SHC decided to change screening tools and use the
Patient Reported Outcomes Measurement Information System (PROMIS) tool instead as it was
already in SHC’s repertoire. PROMIS is a validated and reliable tool developed by the National
Institutes of Health (NIH, date) to capture patient reports of their physical, mental, and social
wellbeing (Appendix I). The information gathered from this tool is intended to provide clinicians
with patient insights as to the effects of treatment to enhance communication between patients
and their healthcare professionals and to foster patient-centered treatment plans (NIH, n.d.).
Phase two: Design workshop. In February 2015, a multidisciplinary group of 25
patients, family members, oncology clinicians, and experts in patient experience and health
services research convened to evaluate SHC’s current state of PM and to formulate options for
interventions. During this one-day workshop, small, multidisciplinary groups were formed and
breakout sessions occurred throughout the day to provide space for participants to generate ideas
for innovative models of cancer care. This working group identified five areas of focus for
meeting patient and family needs and overcoming stated barriers: automated/standard processes
for access to PM, education on primary PM, rapid reporting of outcomes of integration,
relationship-building with referring clinicians, and improving access to primary and specialist
palliative care resources. As a result, four interventions were developed and tested to address
these, one of them being patient-reported outcome distress screening.
Phase three: PROMIS screening rollout. With momentum from the design workshop,
this author along with Dr. Ramchandran, an evaluation specialist and biostatistician, a patient
advocate who is the Chair of the Stanford Cancer Institute Patient Advisory Council, and a
program designer/research assistant formed a team that would be responsible for operationalizing
the PROMIS global screen to assess, monitor, and manage cancer patients’ needs along their
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cancer care trajectory. Over the next three months this interdisciplinary group met weekly for
one to two hours with the overarching goal to redesign the cancer patient experience through
greater access to palliative care services for those who need them. To achieve this goal, the
design team focused on designing a standardized process to best identify and meet patients’
supportive care needs, which we determined was early screening of patients’ physical, social,
emotional, and spiritual wellbeing. We developed a pilot project which we had planned to test in
the Gynecologic Oncology clinics given that small tests of change had already taken place in this
setting. From the plan-do-study-act (PDSA) cycles—a methodology for conducting tests of
change by trial and evaluation (Institute for Health Improvement, 2015)—that would ensue, we
would then develop our “ideal state” for screening and managing identified patient needs. This
“ideal state” however, was unable to be actualized as the PROMIS screening tool was
prematurely launched SCI-wide without any standardized processes in place.
Dr. Ramchandran was our project design team lead. The rest of the team members played
specific roles according to their area(s) of expertise. We had a program designer/research
assistant who prepared the agenda and visual documents for our meetings as well as immersed
herself in all aspects of the project, creating relationships and forming professional alliances; our
evaluation specialist helped develop our metrics, surveys, and evaluation measurements; our
patient advocate offered the perspective of patients and their families and kept our focus on
patients and family-centered care; and this author brought the perspective of a nurse leader and
clinical expert in hematology/oncology nursing, along with her newly-acquired skills of
evidence-based practice research and project planning.
Each of the team members had homework assignments to complete between meetings.
This author focused on research and document development, which included:

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  
•

literature reviews;

•

the development of an evidence-based practice algorithm for distress and symptom
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management (Appendix J);
•

surveys for RNs (Appendix K) and medical assistants (Appendix L), for metric
purposes;

•

a one-page document explaining the purpose of PROMIS for healthcare professionals
to reference (Appendix M);

•

a gap analysis (Appendix D); and

•

a Gantt chart for timeline purposes (Appendix N).

This author attended several meetings outside of our weekly design team meetings with other
stakeholders and collaborative partners to inform others about the workings of our group, discuss
the utilization and feasibility of PROMIS, and obtain feedback and suggestions for
implementation strategies and staff support.
Communication among team members often took place over email or in person at either
our weekly meetings or other meetings that were established on an as-needed basis. There was
no formal communication matrix established among our design team members; however, the
information from our meetings was disseminated to leadership and other key stakeholders in a
hierarchical fashion (see Appendix O for the communication matrix). When needed, we invited
various colleagues to our meetings for the purposes of sharing updates, collaborating on action
items and next steps, and facilitating closed loop communication. Other collaborating members
included the Integrative Cancer Care Program (ICCP) Service Center Operations Manager,
Director of SCI Operations, oncology and palliative care social workers, specific Cancer Clinic
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Program managers, psycho-oncology physicians and advanced practice providers, and additional
patient and family advocates.
Once a month, Dr. Ramchandran and our program designer/research assistant would meet
with the Vice President and Medical Director of SCI to discuss the current state of our project,
make specific requests necessary for project completion, and further develop the idea for a
central hub of supportive care resources. Additionally, once monthly they would meet with the
Director of Cancer Center Operations to discuss our information technology (IT) infrastructure
and support as well as operational logistics of PROMIS implementation and frontline staff
support. Every Wednesday night, a large multidisciplinary group of clinicians made up of cancer
supportive program leads, chaplaincy, SCI operations managers, and the Director of SCI
Operations, would meet to discuss the current state of PROMIS, identify gaps, brainstorm
practical and realistic interventions, and create the new model for patient and family cancer care
experience, one centralized hub where every need will be triaged and referred to the appropriate
supportive care service. These meetings also served as good “study” sessions in the PDSA cycle
to report findings, gather feedback for continuous system improvement, and brainstorm next
steps.
Cost/Benefit analysis. This project is funded by a generous donation of $500,000 and is
a component of a larger SCI movement toward transforming cancer care to care that is more
patient and family-centered. This endowment however, was given specifically to fund the design
team budget and not the operations of our project. Moreover, this cost-benefit analysis includes
only known operational costs and revenue pursuant to implementation of the PROMIS tool.
Projected costs and revenue have been estimated for the first three years; year one includes all
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non-recurring development and implementation costs, which are reduced in year two, and
eliminated in year three.
Expenses. The project team consists of a group of seven individuals, a combination of
paid employees and volunteers, and includes project and operational members. For the purpose
of cost estimations, project team costs are expensed for a two-year period, after which time only
operational members remain. Project team members include a Team Lead, a Program
Designer/Research Assistant, the President of SHC’s Patient and Family Advisory council, an
Evaluation Specialist, a Clinical Informaticist, two Patient and Family Advisors, and this author.
Operational team members include the ICCP Service Center Operations Manager, the Assistant
to the ICCP Service Center Operations Manager, and Nurse Coordinator.
The Team Lead, a full-time paid employee of Stanford University, was/will be paid
$30,000/$15,000/$0 across years one, two and three, respectively. The Program
Designer/Research Assistant is a full-time employee who devoted 50% of her time to this
project, at a cost of $25,000/$12,500/$0 across years one, two and three. The only paid patient
representative is the President of SHC’s Patient and Family Advisory council. About 30% of her
time in this role is devoted to this team and project, which estimates annual costs of
approximately $24,000/$12,000/$0. The Evaluation Specialist is a full-time employee of
Stanford University and devotes about 25% of her time working on this project, with three year
costs at approximately $31,250/$15,625/$0. The Clinical Informaticist (CI) was responsible for
embedding PROMIS into the EHR, developing evaluation reports, testing, participating in
meetings, and assisting to train the pertinent clinicians in its use. The CI spends approximately 5
hours per week (12.5% of his time) on PROMIS-related matters, estimating a total cost of
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$9,375/$4,687.50/$0 in the first, second, and third years. The remaining three individuals—this
author and two additional patient and family advisors—are volunteers.
Additional personnel expenses are for the Integrative Cancer Care Program (ICCP)
Service Center Operations Manager, her assistant, and the Nurse Coordinator(s), accounting for
the project’s recurring operational expenses. Approximately 30% of the of the ICCP Service
Center Operations manager’s responsibilities is devoted to PROMIS, costing SCI approximately
$33,000 annually. Additionally, 30% of the ICCP Service Center Operations manager’s
assistant’s time is devoted to PROMIS-related duties, resulting in a cost of about $13,500 per
year. It is estimated that 20% of the Nurse Coordinator’s time will be allocated to the review
questionnaires, and coordination of appropriate follow-up on identified needs, costing roughly
$30,000 annually. Because patients are responsible for completing the PROMIS questionnaire,
there is no additional expense for administering the tool.
An average of 4.45% of patients (n = 47) who complete PROMIS have relevant answers
(see Appendix P). This could mean that approximately 50% of patients with relevant answers
would be referred to social work or palliative care. Using this assumption as a constant for
budgetary purposes, this means roughly 2.22% (n = 23.5 patients) completing the PROMIS tool
will be referred to social work or palliative care, resulting in 11.5 new patient visits per month
for social work, and 12 new patient visits per month for palliative care as a result of PROMIS.
Conservatively assuming that an average of 50% of these newly referred patients will
require ongoing evaluation and management (E&M) services once monthly for three months,
then at any given month during the year, the quantity of patients receiving established patient
E&M services will be equivalent to those newly referred to social work and/or palliative care as
a result of PROMIS. For example, if 12 patients are referred to palliative care in July, six of
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these patients will require established patient E&M services in August and September. However,
in August, a similar cohort of patients newly established in June (n = 12) will also require
established patient E&M services, increasing the volume of established patients in palliative care
to 12, in addition to the 12 new patient visits generated in August, for a total of 24 patients per
month as a result of PROMIS referrals. This same logic is applicable to service line social
workers as well.
Financially speaking, if there are a total of 144 new patient visits and 144 established
patient visits annually to palliative care (based on the logic described above), the net costs to the
institution would approximate $34,615 (see Appendix Q for cost/benefit analysis). This cost is
the sum of the Palliative Care Physician and the Palliative Care Nurse Practitioner (NP) time
spent in new and established patient visits as all patients receiving a palliative care consult and
subsequent care are seen by a team of a Palliative physician and NP. Receiving the balance of
new patient referrals—and providing the above outlined established patient follow-up services—
service line social workers would conduct 138 new patient visits per year and 138 established
patient visits per year. This results in a net cost to the institution of $8,846. Moreover, supportive
care services personnel cost the organization a total of $43,462 as result of increased referrals to
palliative care and social work (see Appendix Q for cost/benefit analysis).
Non-personnel expenses, including training supplies (i.e. copy paper, printer, printer ink,
markers, snacks, T-shirts, and conference room use), outreach and marketing costs, and
equipment and facilities, total an additional $3,500 annually. In sum, year one PROMIS related
costs total $234,087. Year two costs are significantly reduced (the time devoted to PROMIS
development and implementation is reduced by half), at $174,114. And finally, year three costs
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exclude all development and implementation expenses from years one and two, resulting in a
true operational budget of $114,302.
Profit. The revenue generated from PROMIS was calculated based on reimbursement
rates for E&M services rendered by palliative care and social work. Therefore, the annual
generated revenue from 144 new patient visits to palliative care is $46,800; annual revenue
generated from 138 new patient visits to social work is $27,600. Total reimbursement for 144
established patient visits to palliative care is $28,080 and $16,560 for the 138 established patient
visits to social work. These projections result in an estimated total annual revenue of $119,040
resultant from PROMIS-related services.
A few significant assumptions were made in the revenue calculation: (a) there will be no
increase in the number of new and established patient visits per year to both supportive care
services, (b) there will be no inflation in personnel salaries, and (c) there will be no increase in
the reimbursable value of E&M services. The above analysis of the tangible costs and benefits of
PROMIS implementation and ongoing use actually result in a net cost to SCI. Although there is a
26% reduction in costs in year two and additional 35% decrease in year three, these projectbased implementation costs result in a $170,121 deficit after the first two years. However, a key
point to note is that other relevant frames for analysis—such as the consumer frame, the
insurer/payor frame, and the societal frame—would consider this project to have associated
benefit in terms of overall healthcare resource utilization (Meier, 2011; Simeons et al., 2010).
Breakeven analysis. Assuming there is: (a) no increase in patients completing the
PROMIS tool; (b) no increase in patients with relevant answers on PROMIS; (c) no increase in
referrals to supportive care services; (d) no increase in new and/or established patient E&M
services; (e) no increase in personnel wages; and, (f) no increase in reimbursement rates for
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billable services, it is projected to take 38 years for the organization to break even (Appendix R).
It is important to note this breakeven analysis excludes potentially relevant but less tangible
benefits to the organization (e.g., reputational/marketing benefits, repeat customer benefits,
prestige benefits [e.g., top talent attraction and retention], etc.).
Implementation of the Project
In June 2015, the collection of patient-reported outcomes (PRO) using the PROMIS
global screen was launched electronically throughout SCI, which includes 12 cancer care
programs (CCPs) encompassing 22 cancer clinics. The PROMIS screen was delivered to patients
via their online health account three days prior to their first return patient visit. If not completed
prior to this visit, the opportunity to complete it on the computer in the exam room while waiting
for the physician was offered by the medical assistant. Once completed, PROMIS was sent
electronically every 30 days thereafter. This author developed an algorithm to facilitate timely
and efficient communication of patient care needs, as well as create standardized clinical care
pathways to meet the identified need(s). This algorithm encompassed referrals to both primary
and specialty cancer care services (e.g., oncology service line social work, psychological
oncology, palliative medicine, and integrated medicine).
Beginning Monday morning, June 8, each medical assistant was instructed to identify
whether or not the patient had filled out the PROMIS questionnaire. This author along with a
small team comprised of the design team program designer/research assistant, the ICCP Clinical
Operations Manager, and her administrative assistant, sat with every medical assistant and taught
them how to add a specific column to their electronic medical record clinic view so that this
would be easy to identify. We also taught them how to view completed questionnaires and how
to assist patients in filling out the questionnaire electronically. We educated them on the purpose
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of the PROMIS questionnaire and instructed them to notify the RN or APP is the patient had
answered fair or poor to any of the questions, signifying relevant answers and thus needing
follow-up.
We did this everyday for the first week of the PROMIS tool launch. Additionally, we
circulated in every cancer care clinic providing additional support to RNs, APPs, and physicians
also assisting them to incorporate the PROMIS questionnaire into their electronic medical record
dashboard and also explaining in greater detail what the PROMIS tool is, its purpose and our
intended use. We also informed these clinicians of the MA workflow and instructed the RNs and
APPs to make referrals as they normally would, based on the indicated relevant answers from
the PROMIS tool (Appendix S). Each day during the first two weeks of launching PROMIS, we
would put up a large piece of white paper on a wall, outside of the clinics, where we created a
parking lot of issues, feedback, and ideas. At the end of the day we would consolidate,
summarize, and send out nightly reports from our design and implementation teams to the
Director of Clinical Operations, all CCP managers, and the Vice President of SCI.
Planning the Study of the Intervention
Approximately 57% of Stanford cancer patients indicated that their health care team
provided whole-person, compassionate care. Only 39% reported that their oncology teams asked
about their physical, emotional, and social goals (n = 248). From patient interviews conducted by
our design team, Oncology clinicians cited needing support in identifying and tracking holistic
needs (E. Tribett, personal communication, September 16, 2015). Until June 8, 2015, there was
no standard screening and tracking of distress at Stanford Cancer Institute (SCI). On June 8 a
standard screening process using PROMIS global screen and referral algorithm for supportive
services was implemented. Triggers were embedded into the electronic medical record to prompt

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  

58

discussion of PROMIS and potential specialist support. The ultimate goal of this intervention
was to regularly screen, assess and develop management plans for patient wellness in hopes of
changing the conversation between patients, families, and providers to address impacts of cancer
and its treatment on overall wellness.
Metrics. To effectively measure success, we developed metrics that were measurable
with the ability to utilize electronic reporting through the EHR system. Our primary process
measures included the following:
•

number of patients who received a PROMIS questionnaire;

•

number of patients who completed a PROMIS questionnaire;

•

number of patients with identified needs (indicated by relevant answers, an answer of
fair or poor on any one of the PROMIS questions);

•

number of patients with identified needs that were addressed by their oncology team;

•

number of patients with identified needs who were referred to supportive care
services (specifically palliative care and social work for the purposes of this initial
project phase);

•

number of patients with identified needs who were seen by the consulting service.

In order to measure whether patients perceive a change in the conversation between them
and their healthcare providers we plan to correlate Press Ganey scores as well as conduct
additional patient surveys (which have already been instituted) to determine whether the care
team asked about physical, emotional, social and spiritual goals; whether their treatment plan
considered physical, emotional, social and spiritual goals; whether their care team explained how
cancer and treatment would impact daily activities; and whether their care team delivered wholeperson care.
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Using the PDSA quality improvement design process we plan to run rapid cycles of
evaluation every week for the first four weeks of implementation and at three months, six
months, nine months, and one year. Additionally, we developed surveys for both RNs and
medical assistants (MAs) to obtain qualitative feedback about the PROMIS tools’ effectiveness
and ease of use as one of our evaluation measures (Appendices K and L).
Critical milestones. While considered somewhat of a failure at the time, the inability of
the Palliative Care Outcome Scale (POS) to screen patients into palliative medicine was a
milestone as it gave us great insight into the needed education and training of the RNs to have
discussions around palliative care needs, important characteristics of a screening tool, and the
need for an electronic tool for ease of use and the ability to trend responses overtime, create
reports for outcome evaluation purposes, and build in automated systems for alerts and referral
algorithms. Another critical milestone was the publication of the Quality Oncology Practice
Initiative (QOPI) guidelines (ASCO, n.d.) that require every patient to be screened for wellness
by their second oncology visit in order to be an accredited cancer program. This guideline
created a sense of urgency for project development and implementation as well as inducted
leadership buy-in and partnership. This guideline also highlighted the importance of addressing
palliative care needs and bringing whole-person care to the forefront of cancer care.
With the rollout of PROMIS also came a dedicated EHR support liaison whose primary
responsibility was to assist with electronic report development and the creation of clinical
decision support tools. The gift of this role to our team was significant as it allowed for
feasibility of outcome evaluation and reporting functionality. Furthermore, this role solidified
stakeholder buy-in as this person was directed to our team by SCI leadership and instructed to
fulfill our requests for the purposes of information gathering and dissemination. In addition to IT
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support, operational support was provided by the Director of Clinical Operations through a new
role developed for the purposes of the Transformation Initiative: the Integrative Cancer Care
Program Clinical Operations Manager. Part of this role’s primary responsibility was to oversee
the operational side of the PROMIS screening and partner with the design team on process
improvement efforts.
Timeline. The timeline for this project spans almost two years. The beginning workings
of this project first started in early 2014 and will continue into 2016. There were many project
iterations that ensued over the course of this project timeline. This author’s project prospectus
was approved in December 2014, providing permission from USF and added support to assume a
major leadership role in planning, implementing and evaluating the project (Appendix N).
Anticipated Outcomes
Given that prior to this project SHC had no universal form of standardized distress
screening, the institution of a screening process SCI-wide is significant and its implementation
alone provides substantial improvement from baseline data and meets the primary project goal:
for all patients to be screened. Additionally, the information gathered from our chart review
indicates that less than 20% of gynecologic patients were screened for distress; however, over
40% of patients had indications for distress that went unnoticed as a result of no formal screening
process. Anticipated outcomes of this project include the following:
•

improved coordination of care;

•

enhanced abilities of patients and families to identify and articulate their needs and
desires to their care teams;

•

normalization of asking about patient well being for clinicians, patients, and families
alike;
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enhanced attention to the dimensions of well-being during clinic visits and incorporation
into treatment plans;

•

more appropriate and timely access to support care services;

•

developed standardized procedures and protocols for identification of patients in distress
(i.e. with physical, psychological, emotional, or spiritual needs), referral criteria, and
follow-up documentation;

•

increased number of referrals to support services; and

•

designated standard roles and trained personnel who hold referral responsibility.

Methods of Evaluation
A mixed method approach, using both qualitative and quantitative analysis, was
employed to gather comprehensive evaluation information.
Quantitative. We will assess the percent of patients screening positive for distress,
which is defined as any one answer of fair or poor on the PROMIS screen. If screened positive
for distress, there will be a red exclamation mark next to the patient’s questionnaire when viewed
in the EHR. From this we will assess the rate of primary palliative care interventions. Primary
palliative care interventions are defined as those interventions carried out by the patient’s
primary oncology team. We will also assess rate of referral to specialist palliative teams and
social work (operationalization of this metric is still in process). Ideally, we would be able to
have reports detailing the following information, which are essentially our metrics:
•

number of return cancer patients who received PROMIS screening;

•

number of return cancer patients who completed PROMIS;

•

percent of return cancer patients who completed PROMIS;

•

number of return cancer patients with identified needs via PROMIS;

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  
•

percentage of return cancer patients with identified needs via PROMIS;
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number of completed screens associated with a referral to social work and/or palliative
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care;
•

percentage of completed screens associated with a referral to social work and/or palliative
care;

•

number of patients screened whose needs were not picked up by PROMIS, but who were
referred to subspecialist services;

•

percentage of patients screened whose needs were not picked up by PROMIS wellness
survey, but who were referred to subspecialist services; and

•

number of patients with identified needs managed by oncology team.

(see Appendix T anticipated outcomes paired with specific metric for evaluation).
Many of our objectives have yet to be met as we are still in the process of working with
IT to create the desired reports electronically so that we can measure the above metrics. To date,
the only metrics we have been able to implement are: the number and percent of patients who
received PROMIS; the number and percent of patients who completed PROMIS; and the number
and percent of patients with identified needs, otherwise known as relevant answers (see
appendices P and W). Anecdotally, our social work colleagues are seeing an increase in referrals
related to PROMIS. However, we do not have official data as we are in the midst of creating an
electronic report through the EHR to specifically capture the number and percent of patients who
are referred to social work and/or palliative care as a result of their PROMIS screen, as well as
the number and percent of patients with relevant answers whose need(s) are addressed by their
primary oncology team. If possible, we would like to further breakdown all referrals and analyze
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them to also identify patients who do not screen positive by PROMIS who are still referred to
specialist services, to better understand the breadth of patient needs.
In theory, these metrics work to meet our objectives of increasing access to supportive
care services, ensuring the distribution, screening, and conversation around PROMIS is part of
everyday practice, and that the process for evaluation, follow-up, and monitoring is streamlined.
Depending on the results of our metrics, our team will have a better sense of whether our
objectives are being fulfilled. For instance, if we obtain percentages on the number and percent
of patients being referred to social work as a result of PROMIS, and it is significantly greater
than the current referral rate, than we can infer that indeed patients are gaining access to
supportive care services as a result of screening.
Qualitative. Both informal and formal qualitative methods of evaluation were used.
During the first two weeks of implementation, support personnel were circulating in each of the
CCP clinics and workrooms to answer questions and assist with tool utilization, while at the
same time gathering real-time feedback on tool utilization, feasibility, and purposefulness. We
put this feedback on a large sheet of paper we posted on the back wall of the clinic to inform
others of our implementation processes and also helped serve as the Study component of the
PDSA cycle. After the first two weeks, it became the responsibility of the ICCP Clinical
Operations Manager and her administrative assistant to continue interviewing and circulating in
the clinics and workrooms every week. At the end of the week, the ICCP Clinical Operations
Manager sent out summaries of her findings and we would discuss modifications or changes at
our design team meetings.
Additionally, this author created feedback surveys for both RNs and MAs (Appendices K
& L) to obtain insight into the utility, feasibility, and applicability of the PROMIS tool to their
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clinical practice. This author received both Dr. Ramchandran’s and the evaluation specialist’s
approval prior to distributing this survey. The survey questions were reviewed by this author, the
program designer/research assistant, and the evaluation specialist, all with content expertise. The
survey consisted of Likert-type scale questions in which respondents indicated the phrase that
best corresponded to their position on the asked question. There was also space after each
question to free text comments. There was a total of ten questions on the RN survey and five
questions on the MA survey.
The surveys were created in SurveyMonkey, an electronic survey development platform,
and were sent electronically via email. The RN survey was sent out two months post PROMIS
tool implementation. We plan to re-administer these surveys six months post implementation.
The data received from these surveys were used to provide formative information for feedback
loops for program improvement. We are in the process of collecting MA survey responses.
SWOT analysis. Implementation of an organizational-wide practice change will
undoubtedly be met by skepticism, enthusiasm, disinterest, or pessimism. An analysis of the
strengths, weaknesses, opportunities, and threats (SWOT) of incorporating palliative care into
routine oncology care through the utilization of a standardized assessment tool (PROMIS) is an
attempt to anticipate and identify strategies that will aide in the successful implementation and
sustainability of this proposed practice change (Larson & Gray, 2014; see Appendix U for a
detailed SWOT analysis).
Strengths. This project has many strengths, both on an operational and theoretical level.
At the operational level, the implementation of screening at the second oncology visit and every
30 days thereafter provides earlier access to palliative care and supportive care services thereby
integrating palliative care into routine oncology care, a national goal and new standard of
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oncology care (Hui & Bruera, 2015; Smith et al., 2012; ASCO, n.d.; Lazenby, 2014; McNiff,
Bonelli, & Jacobson, 2009). Screening patients for distress also encourages active participation
on behalf of the patient in their plan of care, prompting the patient to share a problem(s) that
might otherwise be overlooked or squelched (Bennett, Jensen, & Basch, 2012).
Furthermore, the utilization of electronic patient-reported outcomes (ePROs) aids in more
efficient monitoring of patients’ symptoms and treatment response over time, as well as monitors
the effectiveness of interventions employed. Through electronic health record (EHR) alerts or
clinical decision support tools, an ePROs system can also readily alert the clinician to needs
identified through screening for prompt intervention, positively impacting patient management
(Chen, Ou, & Hollis, 2013). This in turn enhances clinical workflow, increasing efficiency in
patient care (Smith et al., 2014). The personnel for this project are either established employees
or volunteers; therefore, no additional expenses were needed for the implementation of this
project. SHC currently has a robust team of palliative care clinicians as well as disease-specific
social workers available for supportive services referrals. Lastly, this project circumvents
selection bias as screening is offered to all cancer patients, regardless of their disease type or
stage, demographic or socioeconomic status.
Weaknesses. According to the gap analysis, many oncology clinicians do not feel
adequately prepared to address supportive care needs and more specifically, psychosocial
issues—this poses both a weakness and a threat for this project. It poses a weakness because the
purpose of screening for distress is to identify areas of need. Once identified, this means having
conversations with patients that many clinicians feel unprepared to have. This also poses a threat
because if clinicians do not feel somewhat comfortable with having a potentially difficult
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conversation, patients will not feel comfortable or safe engaging in conversation and may not
view screening as useful.
Additionally, time constraints, charting responsibilities, patient volume, and a chaotic and
busy environment all represent weaknesses as well as threats to the success of this project.
Furthermore, there is no one screening tool that is identified as being superior to all the rest, nor
are there specific guidelines detailing how to implement screening and clinical care pathways.
Since there is no standardized algorithm for triaging screening responses, interpreting the clinical
relevance of screening responses is somewhat left up to clinical judgment (Bennett, Jensen, &
Basch, 2012). This can threaten the validity and reliability of the screening tool itself as well as
the attempted standardization of clinical care pathways. Additionally, whether a patient receives
a referral is at the discretion of the oncologist, potentially limiting a patient’s access to services
depending on the clinician. Lastly, PROMIS is only administered in English, excluding any nonEnglish literate patient from participating. Future learning from this project will help identify
what responses are clinically significant and whether or not to raise the threshold of what
indicates a positive screen.
Opportunities. Stemming from this project are many opportunities for growth and
development. From a project development standpoint, no studies to date have demonstrated the
impact of PROs on quality improvement, transparency, accountability, public reporting,
improved system performances, or impact on health outcomes (Chen, Ou, & Hollis, 2013). This
project touches a few of these areas potentially allowing SHC to unveil some key findings that
could provide greater insight into these areas of question. This project provides several
opportunities: (a) to de-fragment care, (b) to enhance rapport among clinicians and patients as
well as among interdisciplinary partnerships, (c) to improve symptom management thereby
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improving QOL, (d) to change the culture and perceptions around palliative and psychosocial
care, (e) to integrate palliative care into routine oncology clinical practice, (f) to facilitate more
informed decision-making, and (g) to potentially achieve cost savings if less patients visit the ED
or are admitted to the hospital due to poor symptom control.
The integration of an ePRO system for screening provides the opportunity to streamline
clinician PRO review into their workflow (Bennett, Jensen, & Basch, 2012). The use of
screening also provides meaningful information for patients, their caregivers, and clinicians
(Wagner et al., 2015; Snyder, Jensen, Geller, Carducci, & Wu, 2010) and allows the opportunity
for enhanced patient-provider communication (Chen, Ou, & Hollis, 2013; Carlson, Waller,
Groft, Zhong, & Bultz, 2012). This project also serves to raise awareness to the importance of
incorporating psychosocial care into medical care and improve clinical practice (Jacobsen &
Wagner, 2012). Ultimately, this project has the opportunity to completely transform and
standardize how we identify, evaluate, and manage physical, emotional, social, and spiritual
needs.
Threats. As mentioned above, limited training in how to ask and respond to questions
about distress poses a threat to both patient and clinician engagement, and could have a
detrimental impact on patient perceptions of the usefulness of screening. Misconceptions about
palliative care, its usefulness, impact, and importance also threaten the success of this project.
Screening in any form can exclude patients with low literacy levels, language barriers, and visual
or physical impairments (Pirl et al., 2014).
Budgetary return on investment. The year-one total expenses estimated for the
implementation of PROMIS (which includes PROMIS personnel, supplies, and supportive care
services personnel) is $234,087. The total annual revenue from reimbursements for palliative
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care and service line social work for new and established patient visits is $119,040. This results
in a return on investment of 51%. While this value indicates that while there were some positive
financial benefits to this work, the return is not sufficient enough to recover implementation
costs. However, because this project was funded by a private donation (of $500,000) there was
no expectation of a profit. More important than any financial gain, screening (as a result of this
project) has the potential to bring great value to patients through better and earlier identification
of comprehensive care needs and prompt intervention of identified needs. Theoretically, such
care can enhance quality of life through more effective care and management of symptoms and
treatments, which provide invaluable benefit to the patient (see Appendix Q for further
breakdown of profit/loss summary).
Analysis
Qualitative analytic methods. Self-report surveys were administered to every nurse
coordinator, an outpatient RN who is responsible for an oncologist’s patient population or a
CCP, in SCI to get their initial feedback on the PROMIS questionnaire. This author, in
collaboration with Dr. Ramchandran, the program designer, and the evaluation specialist
developed a total of ten questions. The first nine questions were written with a corresponding
Likert-type scale, where each response corresponds to a number from one to five with one
indicating a poor or negative association and five indicating a positive or good association. The
tenth question is an open-ended question in which participants were asked to mark all that apply.
Every question provided a comment box for the participant to elaborate on their response or
comment further.
The ten survey questions inquire about three categories: ease of use, utility (i.e. is
PROMIS useful, relevant, and in alignment with patient needs), and training and development.
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There were no comparisons or associations sought among RN responses nor were there
computable means or standard deviations. This survey was developed for the sole purpose of
assessing current state of PROMIS, as well as obtain RN feedback in order to develop further
training and make process improvements. Because of the haste with which PROMIS was rolled
out, there was no opportunity to train the RNs prior to launching PROMIS, thus the design team
decided to administer this survey to the RNs three months after implementation, once RNs were
briefly trained and had time to incorporate PROMIS into their workflow. We plan to administer
this same survey again in January 2016, six months after implementation. Over the next three
months we will take the feedback we received from the surveys and develop intervention(s)
according to the identified needs of the RN, as indicated in their survey responses. We will use
the January responses to compare and contrast the current survey responses
Quantitative analytic methods. The design team formulated the specific evaluation
metrics, but relied completely on the EHR IT team to build the reports electronically from which
the data could be extracted and reviewed. For the purposes of the initial PROMIS rollout, the
primary measures of interest were (a) the total number of PROMIS questionnaires sent out (i.e.
total number of patients who received the PROMIS questionnaire), (b) percentage and number of
completed PROMIS questionnaires, and (c) percentage and number of relevant answers. The IT
team also included the location where the questionnaires were filled out, whether it was
completed in clinic or via their online health portal, MyHealth. SCI leadership decided upon a
target completion rate of 60%. Unfortunately, no CCP has yet to meet this target.
Qualitative findings. A total of 23 RNs responded to the survey, out of 30; this
represents a 77% response rate, much better than we were anticipating. While the responses
provided by the 23 RNs varied, there are some overall trends.
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Ease of use. The majority of RN respondents (n = 16, 56.5%) found it somewhat easy
and very easy to navigate the EHR to access PROMIS (question 6 and 7).
Training and Development. While a majority of RNs indicated they received somewhat
adequate or very adequate training around how to utilize PROMIS and access resources to meet
patients’ emotional, physical, and practical needs (question 9), only 47.8% indicated being
somewhat clear (n = 2, 8.7%) or very clear (n = 9, 39.1%) in how to follow-up on identified
needs (question 8).
Utility. The NC responses regarding the PROMIS questionnaire’s utility is less definite,
with responses dispersed along the spectrum. There is disagreement about PROMIS’s
effectiveness in identifying patients’ emotional, physical, and practical needs. Approximately
22% of RNs report PROMIS is somewhat effective as a screening tool; another 22% report being
not sure; and yet another 22% report it being very effective (question 1). Conversely, 43.5%
report the tool as somewhat accurately representing patients’ emotional, physical, and practical
needs (question 2). There also appears to be uncertainty about the PROMIS tool’s usefulness to
practice. For example, 31.8% (n = 7) are not sure how the tool has enabled informed discussions
about patients’ holistic care needs and 31.8% (n = 7) indicate the tool is somewhat helpful in
facilitating these discussions. Eighteen percent (n = 4) see the tool as somewhat unhelpful
contrasted by 31.6% (n = 3) of RNs who see it as very helpful (question 3). Similarly, 31.8% (n =
7) of RNs are not sure if the PROMIS has helped facilitate referrals to other services; 27.3% (n =
6) think it has been somewhat helpful, while 18.2% consider it somewhat unhelpful (n = 4; see
Appendix V for the detailed breakdown of responses by questions).
Quantitative findings. Completion rates, defined as the number of PROMIS
questionnaires that were completed by patients from the total number of PROMIS questionnaires
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distributed, were collected between June and September 2015. The Gynecologic and Breast
Oncology clinics went live with the electronic PROMIS questionnaire in April 2015, so
completion rates were collected for these clinics starting in April. During this initial month, both
clinics achieved their highest completion rates: 37.3% completed in Breast and 26% completed
in Gynecology. These rates quickly plummeted in the following months, with a slight increase to
17.1% completion in September for Breast and 16.9% in Gynecology (see appendix W for a
detailed breakdown of completion rates by CCP).
During the initial rollout of PROMIS in the rest of the CCPs in June, the Head and Neck
Oncology clinic had the greatest completion rate of 38.9%, followed by Skin Cancer and
Melanoma at 24.5%, and Neurology at 16.1%. Urology showed the greatest improvement in
their completion rates. Their initial rate was 3.5% in June, which increased to 14.8% in July, then
34.2% in August, and slightly dipped in September to 21.5%. To date, the highest overall
completion rate is 25.3%, achieved by Head and Neck, and the lowest rate is 0% in Sarcoma
followed by Lymphoma with a completion rate of 4.0%. Appendix W delineates the breakdown
of completion rates per CPP by month.
Although it is not an impressive sample, we have collated six weeks of relevant answers.
Of those who completed PROMIS, these values represent those who had one or more responses
to the right of the line, meaning answers of fair or poor on one or more items on PROMIS (see
Appendix I for PROMIS tool). During the first two weeks, 4.3% of patients had relevant
answers. In week three, 5.3% had relevant answers and the remaining three weeks had a range of
4.8% to 3.6% (see Appendix P for the breakdown of relevant answers).
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Section IV: Results
Program Evaluation
This evidence-based practice change project consisted of several steps with rapid PDSA
cycles dispersed throughout the project planning stages and the initial three months of the project
launch.
PDSA cycle number one. After the decision was made by Dr. Ramchandran and the
Director of Survivorship to use the PROMIS tool, another pilot was conducted with the same
MCC in the same Gynecologic Oncology physician’s clinic. Patients were asked to fill out the
PROMIS tool by hand at their first visit, which was then scanned into the patient’s chart.
However, the MCC never saw the completed PROMIS form as it was turned in with the rest of
the paperwork the patient was asked to fill out prior to their visit. Therefore, positive answers
went unacknowledged and as a result, untreated. Our chart review confirmed this: for patients
with positive answers on the PROMIS tool, there was no mention of their reported symptoms in
the physician visit note nor was there any follow-up documented by the MCC. This required a
PDSA cycle in which the Act phase was to ask for the tool to be made electronic in order to
improve workflow by making patient responses readily accessible, provide real-time patient
responses for clinicians to see and act upon at the time of need, and track responses over time. In
March 2015, this request was granted by the leadership of SCI and the PROMIS tool was made
electronic.
PDSA cycle number two. With the utilization of the electronic version of PROMIS
(ePROMIS) came workflow and logistical problems. The most significant of these was the
destination of the completed PROMIS questionnaires. With the implementation of ePROMIS the
discussed workflow was the completed ePROMIS questionnaires would be sent to the in baskets
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or EHR related email inbox of the various providers for them to view. However, all surveys were
going to all MCCs and there was no provider filter or other mechanism by which to target
patients to their respective MCC- a huge oversight. Consequently, this resulted in very little
action on ePROMIS responses due to the volume of questionnaires received without an owner.
As soon as this problem was realized, we alerted our EHR IT support liaison to this problem.
The Act from this problem was to stop all questionnaires from going to all in-baskets. Instead an
electronic link through the EHR was created and each MCC was asked to individually assess
whether or not each of their patients completed the PROMIS questionnaire.
PDSA cycle number three. With a more effectively integrated ePROMIS questionnaire,
the design team began planning a pilot project in the Gynecologic Oncology clinics with all
physicians, MCCs, and their respective patients. We began developing observation tools we
would use for our initial needs assessment of current workflow and provider and patient
engagement with the ePROMIS questionnaire. After two weeks of observation we planned to
develop a standardized workflow for the MCCs around ePROMIS, making them the owner of
the screening and management process. In theory this included ensuring completion of PROMIS;
triaging needs in real-time; explaining the role of PROMIS as a screening tool and discussing
any identified needs with the patient, in person, when they came for their physician visit; and
making appropriate and timely referrals to necessary supportive services. Our plan was to begin
our observation in June 2015 with plans to implement our created workflow in July, and conduct
a PDSA in the beginning of August. Then, with a revised and more concrete workflow, we
would then pilot in Hematology, as it would align with the role of the MCC being implemented
in Hematology, and we had strong stated interest from the Hematology physicians for standard
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screening and tracking. After refining the process and sharing outcomes with other teams, we
then planned to develop a timeline for rollout in additional cancer care programs (CCPs).
PDSA cycle number four. Despite our plans, on June 8, 2015, SCI went live with the
electronic version of PROMIS throughout all 12 of its CCPs. Not only was the PROMIS
questionnaire launched electronically on this date, but the entire EHR system was changed to a
specific ambulatory care interface, changing how all employees in the outpatient setting
interacted with the EHR. In the two months prior, all outpatient employees went through a twohour training on how to use the new EHR system and during this instructional session, there was
mention of the PROMIS questionnaire being instituted with a brief overview on how to access it.
Needless to say, on the day of rollout, it was clear no clinicians remembered how to access the
questionnaire, and most did not recall that the PROMIS tool was being utilized for patient
screening.
During the first two weeks of launching PROMIS, a small team rounded in all CCPs,
providing electronic support and education about the purpose, importance, and intended use of
PROMIS. Prior to its implementation, clinic managers met with all of the medical assistants
(MAs) to review their new workflow, which now included ensuring the PROMIS questionnaire
was completed prior to each patient visit. If it was not, they were instructed to assist patients to
fill out the questionnaire prior to seeing their physician. Throughout these two weeks this team
collaborated with the EHR IT team who was also present in the workrooms and clinics during
this time. Together we provided answers to various questions, gathered feedback, and
troubleshot identified problems, if possible. For the items that could not be solved straightaway,
we each created our own list of outstanding issues that we took back to our respective larger
teams or escalated the issues to the appropriate personnel. Two items that remain outstanding are
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(a) there is no way for the patient to decline to fill out the questionnaire, and (b) the
questionnaire is not currently offered in any other language other than English.
Dr. Ramchandran and the Director of Cancer Center Operations, with the consensus from
our design team, decided that only return patients, prior to their second oncology visit, would
receive the PROMIS questionnaire. This excluded patients who were coming in for any type of
procedure or treatment; the questionnaire was only sent to patients who were seeing their
oncologists for the second time. This was decided upon out of consideration for patients who
often receive their cancer diagnosis along with a wealth of information at their first visit and in
accordance with the guidelines set forth by QOPI.
PDSA cycle number five. After the first month of implementation, our design team
along with the Manager of the Integrated Cancer Care Programs (our operational partner),
conducted informal interviews with various MAs, RNs, and advance practice providers—chosen
at random based on their presence and availability at the time we were circulating in the
clinics—to obtain feedback on the feasibility of PROMIS and their perceived success of the
tool’s utilization. From these interviews it became clear that neither the MAs nor the RNs felt
entirely comfortable with the tool. The MAs shared they did not feel comfortable assisting
patients to fill out the questionnaire as they did not know how to answer the patient questions
that arose and they did not have the time to sit with patients to complete the questionnaire. If the
patient did not speak English, they had to ask for an interpreter to assist in translating the
questionnaire, which took anywhere from ten to twenty-five minutes. The RNs shared that they
were unsure of their role in relation to the questionnaire and also expressed feelings of
unpreparedness in having potentially difficult conversations as a result of the PROMIS
questionnaire.
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Our Act as a result of this information was five-fold. First, we conducted two one-hour
training sessions with a majority of the clinic MAs to review the purpose of the PROMIS tool, its
content, what we were asking of them, and provided instruction on how to respond to a positive
screening. We identified five questions if a patient answered poor or very much on any one of
those questions, the MAs were to immediately inform the RN, APP, or physician depending on
specific clinic workflow (see Appendix X). Second, we no longer required the MA to stay with
the patient to complete the questionnaire, rather we asked the MA to set the patient up on the
computer in the exam room for the patient to fill out the questionnaire while they waited for their
physician.
Third, we conducted a two-hour training session with all the RNs to review with them the
PROMIS questionnaire, what constituted a positive response, what the new MA workflow was,
and also provided information and education on how to have difficult conversations. During this
time we role-played and discussed various clinical scenarios. At the end of this session we
formulated a tip sheet that each RN could have to help them through a difficult conversation
(Appendix Y). Fourth, we determined the RNs’ responsibility was to only follow-up on any
questionnaire responses they were alerted to by the MA. Last, we created one-page informational
documents for MAs to give to patients explaining the PROMIS questionnaire and for staff that
we hung in workrooms for any member of the care team to reference (see appendices M and Z
for one-page PROMIS informational pamphlet for staff and for patients, respectively).
PDSA cycle number six. In addition to the operational aspects of this project, we also
collaborated with our biostatistician/evaluation specialist to design meaningful and measurable
metrics for reporting and tracking purposes. After three meetings with her, we then contacted our
EHR IT liaison assigned to us to ask for the reports we designed. Over the course of three
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additional meetings we solidified our specified reports. This component, arguably the most
important, was the most difficult deliverable to obtain. It took over two months to receive our
initial requested reports, delaying any further PDSA cycles.
PDSA cycle number seven. This next cycle will take place after the submission of this
paper. In this next cycle we will analyze the data and refine our current processes going forward.
We will use the data to respond to the following questions:
•

Should we change what we are considering to be a positive screen from one item to
two?

•

Should we open up screening to more than just those coming for their second
oncology visit to include patients coming for procedures and treatment?

•

If we find a significant increase in referrals, do we need to formulate a business plan
asking to increase our supportive care services workforce to accommodate the
increase in patient volume?

•

How can we best evaluate impact on screening and supportive services on patient
outcomes?

Our next steps include ongoing PDSA cycles to identify successes and failures of first phase and
develop second phase with the goal to achieve ideal state within 6 months. We also intend to
refine the algorithm for referral to PM/support services and revise the referral process to
PM/support services based on ongoing analysis of patient characteristics and self-reported needs.
We also hope to build the algorithm into electronic referral prompts based on relevant answers,
any responses of fair or poor on any of the items. In addition to this sophisticated use of the
EHR, we hope to also develop electronic triggers that indicate relevant answers. Lastly, we hope
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to acquire and use iPads for survey completion in the waiting room prior to a patient’s clinic
visit.
Outcomes
Since launching the PROMIS questionnaire in June 2015, both our qualitative and
quantitative findings were used for program improvement. We continue to analyze the data,
assess current processes, and develop strategies that will continue to promote integration of
screening, assessment, and management of comprehensive care needs into cancer care. We still
need to develop more concrete workflows for both MAs and RNs as well as design clinical care
pathways so that RNs know how to respond to identified needs. Some of our next steps to
address the current gaps and respond to the feedback we received from the RNs through our
survey include the following: incorporate the use of a standard electronic smartphrase for
PROMIS which the nurse could use to document discussions around PROMIS, develop a
PROMIS-specific referral, and create standard work around reviewing PROMIS. Many RNs do
not see patients in clinic. Building in the process around nurse navigation and advocacy in
addressing survey responses is needed as well as figuring out how best to communicate survey
responses to physicians.
In response to the concerns voiced by many of the MAs and from our observations of
current practice around PROMIS screening, additional next steps will focus on increasing online
completion of PROMIS as well as completion of the questionnaire outside of clinics. This goal is
to take the responsibility for questionnaire completion out of the hands of the MAs. We also
hope that the creation and implementation of best practice alerts will decrease the workload of
the MAs as they will no longer be responsible for alerting the RN or MD to relevant answers as
these best practice alerts will populate upon questionnaire completion for the RNs, APPs, and
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MDs to easily see. Until these electronic support pieces are being developed and tested, we plan
to institute a reward system for the MAs, which will recognize and celebrate certain MAs and
CCPs who obtain the target questionnaire completion rate of 60%.
Although we are waiting on the total number of referrals to social work and palliative
medicine in order to compare these numbers to the number of referrals to these services prior to
the implementation of PROMIS, from informal conversations with both social work and
palliative medicine, there seems to be an increase in the number of referrals to both of these
services as a result of PROMIS. There is also a shared notion that many of the indicated positive
responses are addressed in the first call or first visit with either team. While this is not true
qualitative data, this observation is useful, and demonstrates a seemingly more effective closed
loop communication system.
Section V: Discussion
Summary
Key successes. The ability to implement this project on such a large scale is one of the
greatest successes of this project. The expediency by which this project was executed affords
good and bad consequences, however. It is common at a large academic center for the
implementation of practice changes to be drawn out as there are several layers of approval
needed. Although its conception began two years ago, once the PROMIS tool was decided upon
as the assessment tool, its incorporation into practice did not seem to encounter any barriers.
While there was resistance and hesitancy, mostly by the MAs and RNs, the leadership of SCI
whole-heartedly endorsed this project by considering it a priority for the organization.
Additionally, the use of an electronic screening tool allows for many sophisticated,
evaluation metrics and reporting functionality as well as allows for greater efficiencies both in
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patient completion and clinician review. These capabilities will provide real-time information to
patients and clinicians as well as allow clinicians to track responses (i.e. symptoms) overtime.
Additionally, having an electronic screening tool embedded into the EHR system enables the
development of electronic algorithms which can serve as clinical care pathways, automate
referrals, and develop clinical decision support tools such as best practice alerts to enhance
efficiency and help ensure needs do not go unidentified.
Lessons learned. First, while a major component of this project focused on the screening
tool itself—its selection, feasibility, and electronic format capabilities—a significant learning
point is that it is not about the instrument itself, but the process of identifying needs by way of
the instrument to adequately assess and manage identified needs. In other words, the actual
screening tool does not determine the outcome(s), rather the goal is to use the instrument to
identify needs so they can be met.
Second, any large-scale intervention requires effective frontline clinicians to ensure the
desired outcome(s) are accomplished. We found that in-person support in real-time was greatly
beneficial for the MAs and RNs specifically, as they primarily interacted with patients around
the PROMIS tool. Additionally, because operational barriers are critical issues to overcome
when implementing distress screening, ongoing training and engagement is critical.
Third, it takes more than having a good idea to make a change successful; it takes
operationalization. Therefore, having an operations process owner (the Integrative Cancer Care
Program (ICCP) Service Center Operations Manager) is helpful for implementation,
accountability, and sustainability. Fourth, the incorporation of PROMIS into clinical workflow
needs to be intuitive and easily accessible. Criticism already existed around the amount of time
spent in front of a computer and how navigating the EHR can detract from face time with
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patients (Block et al., 2013; Friedberg et al., 2013). This further corroborates our efforts to
encourage the completion of PROMIS questionnaires online or while waiting. This will allow
clinicians time to review questionnaires prior to patient visits so that responses can be discussed
in person during the visit.
Next steps. There is still much work to be done to maximize the capabilities of electronic
PROs through PROMIS. We still desire to gather more information on how PROMIS is
changing practice and impacting patients, as well as clinicians, hopefully for the better. In order
to evaluate whether screening is indeed increasing patient access to supportive services (i.e.
palliative care or social work), we would like a specific PROMIS referral so we can easily
capture this. From the findings, we could potentially make a case for more staff to provide these
services. Furthermore, we would like to be able to know if providers truly are following up on
relevant answers. In order to do this we have asked for IT to create a smartphrase which would
be incorporated into a clinicians electronic visit note that would populate a dropdown menu from
which the clinician could indicate the action that was taken in response to the relevant answers
identified (e.g., responses discussed and addressed during visit, no further action required,
medications prescribed, or referral made). Additionally, we would like this note to be a hard stop
in the medical record for all patients with relevant answers, meaning the provider would not be
able to close the patient encounter until this action step was completed.
An additional step toward sustainability would be staging. Currently, SHC as an
organization does not stage cancers (e.g. stage I, II, III, IV). While requiring every oncologist to
stage cancer would be difficult, doing so would allow the opportunity to perform more
sophisticated electronic data collection, analysis and stratification of patient needs. For example,
it could potentially allow us to correlate cancer stage and/or type of cancer with specific resource

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  

82

need(s) and utilization. Another step toward sustainability that is currently underway is to
establish more robust electronic decision-making support capabilities. This includes building an
algorithm that would generate automatic referrals to supportive care services. The purpose of this
is to prompt clinicians to either choose to send the referral or choose to address the patient needs
within their own team. We also hope to develop electronic triggers to indicate relevant answers
for more efficient and effective identification of unmet needs.
Next, we plan to be transparent with our findings and engage in sharing our information
with patients and clinicians to further foster engagement and teamwork. We plan to send out
monthly reports to all SCI clinicians on PROMIS utilization, very similar to our process
measures, which include the number of questionnaires distributed, the number of questionnaires
completed, the percentage with relevant answers, and the number of referrals generated as a
result. Lastly, we need to develop strategies to measure whether patients feel their needs are
actually being met by way of screening. One way we plan to do this is to analyze our Press
Ganey scores along with additional survey questions to distinguish whether there have been any
positive impact, as measured by patients’ survey responses. Our team believes in practicing
ongoing PDSA cycles to identify successes and failures of each phase and develop subsequent
phases to achieve ideal state. Eventually, we hope to have the reporting structure in place to
make comparisons among the number of referrals to supportive services pre-PROMIS compared
to after PROMIS, as well as identify if the number of emergency room visits and inpatient
hospitalizations pre-PROMIS differ from post-PROMIS implementation. Ideally, we hope to see
an increase in supportive services utilization and a decrease in the number of emergency room
visits and inpatient hospitalizations due to earlier identification and better management of patient
needs and symptoms.
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Relation to Other Evidence
There has been much work in recent years to devise standards of psychosocial care,
develop clinical practice guidelines, and formulate measurable indicators to assess the quality of
psychosocial care provided in oncology practice settings (Jacobsen & Wagner, 2012). Distress is
not a stranger to cancer patients. In fact, given its broad definition, distress quite possibly may
touch the lives of all cancer patients and those close to them at some point along their cancer care
trajectory. Because of its pervasiveness, national and international interventions have been put
into effect to have distress recognized as the sixth vital sign to heighten awareness and bring
focus to the importance of assessing and managing patient concerns (Dudgeon et al., 2012;
Watson &, 2010; Bultz & Groff, 2009; Bultz, Thomas, Stewart, & Carlson, 2005).
Between 2005 and 2012, there has only been a 7% increase in the use of screening tools
for routine assessment by NCCN Member Institutions. There is additional evidence that suggests
that without the use of screening, cancer care providers do not adequately assess for symptoms or
identify distress (Lazenby, 2014; Chen, Ou, & Hollis, 2013; Jacobson & Wagner, 2012; Bultz &
Groff, 2009; McNiff, Bonelli, & Jacobson, 2009). The NCCN Clinical Practice Guidelines in
Oncology for Distress Management were first developed in 1999. These guidelines are nationally
recognized as the gold standard for the provision of high quality patient-centered cancer care
(Lazenby, 2014; Jacobsen & Wagner, 2012). Per these guidelines, distress is defined as
a multifactorial unpleasant emotional experience of a psychological (cognitive,
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability to
cope effectively with cancer, its physical symptoms, and its treatment. Distress extends a
long a continuum, ranging from common normal feelings of vulnerability, sadness, and
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fears to problems that can become disabling, such as depression, anxiety, panic, social
isolation, and existential and spiritual crisis. (p. 7)
These guidelines provide clear instructions on when and how to best practice distress
management. A few of the recommendations include the following:
•

distress should be identified, evaluated, documented, and readily treated at all stages of
disease;

•

all patients should be screened for distress at their initial visit, at appropriate intervals and
as clinically indicated (i.e. changes in disease status or treatment-related complications);

•

clinical health outcomes, quality of life and patient/family satisfaction, should be
measured when evaluating distress;

•

management of distress is an integral component of the provision of care and information
about psychosocial support services should be provided to all patients and families; and

•

institutional quality improvement projects should include evaluating the quality of
distress management.
The primary reason to screen for distress is to identify patients who may be in a

situational period of increased vulnerability or at an increased risk for distress. These
characteristics are clearly detailed in the guidelines. These guidelines provide various algorithms
for patients who are experiencing varying levels of distress. The NCCN guidelines utilize the
Distress Thermometer and Problem Checklist as their initial screening tools and have determined
a score of ≥ 4 on any of the items on the Distress Thermometer to indicate moderate to severe
distress. The algorithm suggests that any patient in “mild distress” should be first triaged by their
primary oncology team and if necessary, receive a referral for psychosocial support. If patients
are identified as high risk; have practice, family, physical, social, or emotional problems; or have
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spiritual or religious concerns, they should receive a referral to mental health services, social
work, counseling services, or chaplaincy services, whatever is deemed appropriate by the
referring clinician. Follow-up, communication, and collaboration with primary oncology team as
well as with family and caregivers is also recommended (NCCN, n.d.).
The IOM report (2008), Cancer Care for the Whole Patient: Meeting Psychosocial
Health Needs, was a pivotal manuscript that brought psychosocial care to the forefront of cancer
care clinical practice. The report underscored the deficiencies in how we care for the wellbeing
of the cancer patients we so aggressively, innovatively, and scientifically treat with medical
interventions, often disregarding their potential psychological or social problems. In 2011, the
American College of Surgeons (ACoS) founded the Commission on Cancer, a program
dedicated to creating the framework through standard setting, prevention, research, education,
and monitoring of comprehensive quality care so cancer patients may experience improved
quality of life and greater longevity. With the focus on quality of care and health outcomes, the
Commission on Cancer created Cancer Program Standards: Ensuring Patient-Centered Care
which includes standards for distress screening with psychosocial intervention and management
of identified distress (American College of Surgeons (ACoS), 2012).
The American Society of Clinical Oncology (ASCO) through their Quality Oncology
Practice Initiative (QOPI) program has recently required routine psychosocial assessment and
management of cancer patients as part of their accreditation standards. More specifically, all
patients must be screened for distress by their second oncology visit. This initiative has called on
the oncology community to screen for distress among cancer patients (ASCO, n.d.; McNiff,
Bonelli, & Jacobson, 2009). This benchmark, along with the guidelines for standards of
psychosocial care developed by the NCCN, ACoS, and the IOM, are endorsed by the American
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Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and
Oncology Nursing Society (ONS), who are also making efforts to implement these practice
standards on a national level (Pirl et al., 2014).
Distress management through PRO has gained popularity in recent years as it has proven
to be an effective way to screen for a variety of health care needs. PRO questionnaires provide an
avenue for patients to self-report a multitude of symptoms, physical functioning, mental health,
and quality of life. This insight creates the platform upon which clinical practice can be
enhanced. The use of ePRO systems allows for better symptom monitoring, improved
communication among a variety of providers, increased efficiency, and the capability to monitor
patient symptoms over time. Collecting patient responses electronically also allows for real-time
alerts to clinicians if severe symptoms are present, which is potentially time-saving.
PRO questionnaires were first implemented in the setting of clinical trials to assess
product effectiveness (Bennett, Jensen, & Basch, 2012). Since then, several institutions have
incorporated ePRO systems into routine oncology practice. Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins University, Duke Comprehensive Cancer Center, Memorial
Sloan Kettering, MD Anderson Cancer Center, Dana Farber Cancer Institute, Cancer Care
Ontario, and the West Clinic in Memphis, Tennessee represent the majority of organizations
practicing screening for distress and comprehensive cancer-specific needs (Bennett et al., 2012;
Basch & Abernethy, 2011). This evidence-based quality improvement project now places SHC
among these world leaders in screening.
Cancer Care Ontario (CCO) is a pioneer in implementing routine screening for emotional
distress. In 2006, Dudgeon and her colleagues launched a province-wide initiative to screen
cancer patients for emotional distress using the Edmonton Symptoms Assessment System
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(ESAS). This project, named the Provincial Palliative Care Integration Project (PPCIP), was an
initiative endorsed by the cancer centers as well as the community and funded by a variety of
sources to improve care for cancer patients. It was initially piloted with lung cancer patients
only. In addition to screening, algorithms were developed to ensure adequate follow-up on any
identified physical or psychosocial need. This team also developed a system known as the
Interactive Symptom Assessment and Collection (ISAAC) to collect ESAS responses via touchscreen kiosks at the clinic or via the internet. The system maintains a database of each patient’s
demographic information as well as their responses to the ESAS questionnaire. In 2008, the
PPCIP became the Ontario Cancer Symptom Management Collaboration (OCSMC) and
screening was expanded to all cancer patients throughout all 14 Regional Cancer Centers
(Dudgeon et al., 2012).
In the first year of the pilot study, screening with ESAS increased from 3.5% to 47 %. By
the end of the first year, over 10,000 ESAS’s were completed per month. Eighty five percent of
patient respondents indicated that ESAS was an important component of their care as it helped
providers know how they were feeling; 62% reported good control of their pain and other
physical symptoms, and 61% reported feeling their providers incorporated their ESAS responses
into their plan of care (n = 407). Two years later, in 2009 after screening was launched for all
cancer patients, 89% of patients felt the ESAS was important to complete, 79% reported their
providers incorporated their ESAS responses into their plan of care, and 78% reported their
symptoms were well controlled (n = 844). These responses indicate that improved symptom
screening with subsequent documentation leads to improved patient care. While their goals of
screening 90% of all lung cancer patients and 60% of the rest of the cancer population have yet
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to be achieved, Dudgeon and her colleagues remain hard at work to improve the cancer patient
experience across the continuum of care through symptom screening (Dudgeon et al., 2012).
Like CCO, Northwestern is another leading organization in the implementation and
utilization of electronic administration and scoring of PROs for symptom assessment. PROs has
become the new gold standard for quantifying patient subjective complaints—physical,
emotional, spiritual, and psychosocial—and have been found to provide meaningful information
to patients and clinicians alike. The integration of PRO tools into electronic systems have proven
to be feasible, efficient, and provide helpful insight into patient experiences (Wagner et al., 2015;
Bennett et al., 2012).
Wagner and colleagues (2015) implemented the computer adaptable PROMIS screen,
which was integrated into their EHR system, to assess cancer-related symptoms and real-time
communication of how PROs influence clinical practice. Six hundred thirty six gynecologic
oncology patients at the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois,
comprised the study population from November 2011 through February 2014. The PROMIS
computer adaptable test (CAT) was administered to assess pain interference, fatigue, physical
function, depression, and anxiety. An additional psychosocial assessment tool was created from
the NCCN Distress Thermometer and Problem Checklist and a nutritional assessment was
adapted from the Patient-Generated Subjective Global Assessment. There were a total of 40
questions taking, on average, ten minutes to complete (Wagner et al., 2015).
Only patients with a MyChart patient portal account could participate. Every two hours
prior to their clinic visit they received a message prompting them to fill out the PRO assessment
with instructions on how to do so. If patients did not complete the assessment prior to their visit
they were given an iPad upon check-in to complete the assessment survey while waiting.
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Assessment results were documented in a specific section in the EHR in real-time. Clinicians
could easily pull these results into their notes and messages were sent to their EHR inbox if the
patient reported severe symptomatology (Wagner et al., 2015).
Clinical messaging algorithms were developed for each domain assessed. Patients were
asked for their preferred mechanism for follow-up: MyChart emessage or a telephone call.
Eighty four percent of patients indicated they preferred to be contacted through a MyChart
emessage. The electronic PRO (ePRO) assessment was linked with clinic visits: 301 patients
completed the assessment twice, 184 answered it three times, and 129 patients completed the
assessment four times. A total of 4,404 assessment requests were sent through MyChart across
the two-and-a-half-year project timeline. From this total, 3,203 messages were viewed, 1,493
assessments were started, and 1,386 assessments were completed signifying a 93% completion
rate. The authors also measured the completion rates of first assessment requests only: a total of
1,089 first assessment requests were sent. Of these, 435 were started (40%), but only 401 were
completed, representing a 37% completion rate, a somewhat disappointing overall return rate
(Wagner et al., 2015).
Impairment in physical functioning was the most common PRO. Severe was classified as
a T score of greater than or equal to 70. Forty percent of patients (n = 26) had symptom scores in
the severe range for physical functioning. Fifty one percent reported pain interference as mild or
greater; 47% reported fatigue above normal; 43% reported anxiety as mild or greater. Only one
patient reported severe anxiety or depression of the 67 patients who completed the psychosocial
assessment; 66% (n = 407) reported no psychosocial concerns. Of the concerns reported,
information on advanced directives, support with managing stress, and information on financial
resources were the top three areas of need. From the 541 patients who completed the nutrition
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assessment, 33% generated an electronic notification to the dietician. A majority of the messages
were inquiries requesting information on gaining or losing weight, feeling full quickly, loss of
appetite, nausea, constipation, and taste change management.
Northwestern University is one example of a program that has successfully integrated a
robust psychometrically ePRO assessment into daily clinical practice. This enhanced clinician
workflow as screening provides insight into patient concerns and allows for more focused clinic
visits and symptom tracking over time. Efforts are underway to evaluate outcomes of PROs
screening (Wagner et al., 2015).
Duke University has also successfully implemented an ePRO system into their oncology
clinics for the purpose of identifying distressed patients and providing optimal cancer care. After
conducting a validation study among patients with breast, lung, and GI cancers to confirm its
psychometric properties, Smith, Rowe, and Abernethy (2014) chose the Patient Care Monitor
(PCM) version 2.0 as their data collection system. This system is made up of software, ePRO
review of system assessment survey, analytics and reporting infrastructure, and integration into
care. The authors used etablets as the mode of survey administration and collection. Neither the
timing nor the frequency of survey administration was detailed, but reports were generated at
each visit highlighting areas of concern and, if applicable, would generate a past history trending
report. A score of 65 or greater on the Distress and Despair subscale or the selection that they
would be “better off dead” indicated a need for a referral for psychosocial services. A nurse
generated this referral (Smith et al., 2014).
Approximately 11% met referral criteria (n = 17, 338 patient encounters; Smith et al.,
2014). With the implementation of ePRO, the authors have observed greater access to PC
services and increased collaboration and communication among the primary oncology teams and
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the psychosocial providers. Like Wagner et al. (2015), they also found ePRO implementation to
improve clinic workflow as well as experienced a cost savings as manual data entry was no
longer required (Smith et al., 2014).
Given the amount of attention distress screening has received by well-respected national
and international organizations and the initial quality improvement projects piloted by various
leading institutions in cancer care, the work of this evidence-based practice change project is
establishing SHC among these top leaders. Given the work that has gone before and in
accordance with the psychosocial care guidelines and standards of care that have been developed
in response to the overwhelming need to take better care of cancer patients’ wellbeing, SHC is
actually better positioned than many of its predecessors. This project focuses on identifying
cancer patients’ comprehensive care needs through ePRO screening and addressing these needs
through algorithmic clinical care pathways, as well as developing metrics to measure health
outcomes, an important missing component to distress screening highlighted throughout much of
the literature.
Barriers to Implementation
The extent of the barriers encountered during this evidence-based practice change project
stemmed from a general misunderstanding or under appreciation for the work and expertise of
palliative medicine by both clinicians as well as patients. It is possible that the same could be
true of social work, at least at an organizational level; however, this author is not well versed in
the literature to generalize this statement to the greater healthcare system. In retrospect, more
time to explain the nature of the project to frontline staff so as to get their buy-in would have
improved implementation. Additionally, this would have allowed for the development of a more
thoughtful implementation strategy and evaluation plan. While the decision to launch PROMIS

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  

92

provides many benefits and opportunities, as well as allows SHC to be among the leading
institutions which are screening for psychosocial distress early in a patient’s cancer diagnosis,
the short timeframe within which this was executed brought a handful barriers and limitations as
a result.
One of the biggest frustrations and subsequently a primary limitation of this project was
the lack of a formal IT infrastructure in place prior to implementing PROMIS. One of the main
requests of the physicians and advanced practice providers (APPs) in the beginning development
stages of this project was the capability to obtain data from their patients’ PRO and to track
responses over time. Currently, both of these reporting configurations remain undeveloped.
Therefore, during the initial months of the rollout the team received many questions about the
tool’s utility, feasibility, and patient characteristic information and correlation to various support
services accessed for which answers were unavailable.
With the launch of PROMIS, our team was assigned an EHR IT support technician,
which was very helpful; however, the expertise of this person was limited to only certain IT
functionalities so when our request went outside of our contact’s expertise, we then had to meet
with other personnel, taking several weeks in some cases to get in touch with the appropriate
person. In addition, once contact was made and conversations were had, it was also several
weeks before we received any reports. Per our IT contacts, this delay was due to the fact that the
new ambulatory EHR build was rolled out at the same time as PROMIS, and they only had so
many resources and allotted time to devote to our requests, another confounding limitation of
this project.
Another significant limitation of this project was that there was little time to adequately
plan the implementation of this project. Our team was told two weeks prior to the go-live date

PRO SCREENING FOR IMPROVED PATIENT WELLNESS	
  

93

that PROMIS was going to be implemented electronically SCI-wide, which meant we had to set
aside our plans for a pilot project, and scramble to figure out how best to support staff and
patients during this time. The lack of standardized processes and ownership of the PROMIS tool
was a significant limitation. This, in turn, resulted in the absence of formal training of MAs,
RNs, and APPs around the tools purpose, functionality, and processes. Furthermore, this lead to
a lack of clarity in role responsibility and workflow, which are central building blocks for
successful and sustainable implementation.
Also as a result of the hurried implementation timeline, no scoring system was
developed. The PROMIS tool does not have a formal scoring guide; therefore, our team decided
that any patient with at least one response of fair or poor or very much is a positive screening
(termed relevant answers) and action should be taken. Although we were in the final stages of
developing a triage algorithm for RNs and APPs to follow based on patient responses on
PROMIS, this process was halted as a result of the PROMIS rollout. Thus, we instructed RNs
and APPs to only respond to the patients who had relevant answers based upon their already
existing assessment and referral processes. It is quite possible that this arbitrary score caused us
to overestimate patients who qualify for a referral to social work or palliative medicine.
Two additional significant barriers to this project were lack of clinician buy-in and time
constraints on the part of both the MAs and RNs. As mentioned previously, there was almost
universal acknowledgment of the need for standardized screening and clinical care pathways for
addressing identified needs; but once actualized, the support for this endeavor was largely
absent. As a whole, the MAs did not think it should be their responsibility to ensure completion
of the questionnaire nor did they have the time to do it, and the RNs did not want to be
responsible for following up on the questionnaire responses given their full workload, although
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these are all responsibilities consistent with their respective scopes of practice. Physicians and
APPs were largely excluded from the initial rollout phase, outside of being educated on what
PROMIS is and where to access the questionnaire in the EHR, and future plans have not been
solidified as to the extent of their role and involvement moving forward.
Interpretation
Qualitative. While our mixed methods analysis did not produce the successful results
everyone hoped for in implementing a new practice change, our qualitative findings were more
favorable than our quantitative. From the RN responses we received, there appears to be overall
buy-in in the purpose and value of PROMIS, but gaps in knowledge around process and
understanding of their role in screening and utilization of PROMIS were further highlighted by
the survey. This is not a surprise as our team was also aware of these deficits, which were a
result from the inability to solidify a standard workflow prior to implementation. This was also
evident from our informal conversations with RNs during our clinic walkthroughs during the
first two weeks of launching PROMIS. Beyond initial teaching, the capacity of our team
members to return to clinics to monitor whether PROMIS was actually being implemented was
nonexistent, leaving no accountability for utilization and implementation of PROMIS into
standard everyday practice, which mostly likely played a role in the poor integration of PROMIS
into daily workflow. We have plans to solidify a standard RN workflow and clinical care
pathway in our next phase of PDSA. Additionally, we plan to administer the already developed
MA survey for their feedback.
Quantitative. There is much room for improvement to achieve a 60% completion rate
throughout SCI. However, there are several factors that could have influenced the results we
obtained. First, the total number of return patient visits, which is the denominator of our
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statistical equation, was most likely falsely inflated. This is because this number includes
patients coming for chemotherapy or radiation treatment visits, which were not given PROMIS
questionnaires. Only those patients who were seeing their oncologist for the second time
received a PROMIS questionnaire.
Currently, there is no option for patients to decline taking the questionnaire. This means
questionnaires remain unanswered, not only potentially reducing patient satisfaction, but also
artificially inflating the denominator. If patients could opt to decline the questionnaire, they
should be evaluated as a separate category for statistical purposes; for example, out of X number
of patients who received a questionnaire, Y percent declined to answer. An additional
contributing factor to the poor completion rate was the fact that not all CCPs have implemented
PROMIS; not all CCPs have formally adopted this process nor have they promoted its
implementation and incorporation into practice. This factor also contributes to a larger
denominator of return patient visits that have not completed the survey because it has not been
encouraged by their oncology team, despite receiving a MyHealth reminder.
Candidly, our team was somewhat surprised by the low percent of patients with relevant
answers. There are a couple reasons for this. The first reason could be from human data entry
error as all of the relevant answer data were entirely collected by one individual, who manually
reviewed patient charts looking for patients with relevant answers, leaving room for exclusion of
some patients with relevant answers or other data entry errors. Every week there were CCPs with
zero relevant answers but there was no way of knowing whether this was because patients truly
did not have any issues to report, whether patients did not fill out the questionnaire, or whether
CCPs were overlooked during manual chart review.
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Second, we currently have no process in place and no standardized electronic
documentation indicating if relevant answers have been addressed. This could potentially lead to
duplication of relevant answer identification. Our team is in the process of working with IT to
create a hard stop in the EHR that will force the provider to select an action that was taken in
response to the relevant answer(s), such as need(s) addressed during visit or referral placed. This
will in turn reset the questionnaire for the next time it is to be completed and remove the relevant
answer electronic alert.
The one advantage of having a small number of patients screening positive with relevant
answers is that we will have the bandwidth to provide services to these patients. However, it is
difficult to make inferences or conclusions from this small sample of patients with relevant
answers so we will continue to manually collect information until our IT team can provide this
information, electronically, for us. Our hope is to eventually identify specific patient populations
with relevant answers so we can better meet their needs and even anticipate them. Because we
currently do not have a system in place to identify patient characteristics, demographics, cancer
type or stage of disease, it is hard to identify if there is a disease group and/or patient population
that is more prone, or likely, to have relevant answers.
Conclusions
Cancer does not discriminate. It invades the lives of people of all demographics, each
socioeconomic class, every race, the spectrum of ages, male and female alike. No matter the
relationship, cancer leaves a mark on the lives of everyone it touches. Therefore, it is essential to
attend to the holistic needs of patients, families, and caregivers. Early identification of palliative
care needs and integration of palliative services into routine oncology care is essential to
adequately meet the complex care needs of patients with cancer (Quill & Abernethy, 2013;
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Smith et al., 2012). Palliative care is an emerging specialty committed to managing the physical,
psychosocial, emotional, and spiritual needs of oncology patients, their family members, and
caregivers. When utilized early in the cancer diagnosis, the influence of palliative care improves
quality of life based on patient-decided goals, enhanced coordination of care, decreased
occurrence of unwanted and unnecessary medical interventions, increased life expectancy, and
decreased costs (National Quality Forum, 2012).
However, while there has been an abundance of literature on the benefits of palliative
care with oncology care early in the diagnosis of cancer, how early to intervene remains
unknown. Whether palliative care should be offered to patients with curable disease or without
symptoms is still a topic of much debate, highlighting the fact that there is still no agreement on
the criteria for specialist palliative care. Additionally, there remains variability in the extent to
which palliative care is provided by primary oncologists given the range of skills, comfort levels,
and palliative care services offered. Furthermore, when and where palliative care should be
provided has yet to be determined (Hui & Bruera, 2013).
What we learned from this project is the utilization of a screening tool is only the method
by which assessment and evaluation of comprehensive care needs is initiated. Evidence-based
practice guidelines and clinical care pathways must also be in place to manage each symptom
identified in a standardized way. Standard screening using PRO and clinical care pathways may
foster early identification and management of patient’s psychosocial and physical needs. Support
for oncology nurses to lead assessment and connect patients with resources is an opportunity to
incorporate primary palliative care into oncology practice. The use of structured, adaptive, novel
algorithms is a promising approach to meet patient needs and improve access to supportive
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resources. Oncology nurses are ideally situated to provide quality, accessible interdisciplinary
care coordination crucial to patient-centric management of cancer care across the continuum.
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Appendix D: Gap Analysis Inspired by the Chronic Care Model

Element
Delivery System
Design
Efficient and effective
provision of care

Decision Support

Gaps Identified
•

•
•

•

Utilization and
Implementation of
evidence-based practice

•

•

Self-Management
Support

•

Patient empowerment

•

•
•

Gaps Met

Poor involvement of
interdisciplinary care
teams
Fragmented care
Lack of orchestrated
palliative care (PC)
clinical pathways

•

Lack of knowledge of
palliative
medicine/Patients
unaware of what it is
Name “palliative
care” has negative
connotation;
associated with death
Referrals based on
individual
physician/APP
choice/preference
Delayed recognition
or inquiry of patients’
preferences, desires,
or goals
Lack of knowledge re
available
resources/support
Poor access to care
Lack of advance care
planning

•

•

•

•

Proposed Solution

Establishment of both
inpatient and
outpatient PC teams,
consisting of
physicians, APPs,
CNSs, and SWs
Organization
supportive of
Palliative Medicine
PC teams actively see
patients
Brochures created
and patients who
receive consults are
educated on PC

•

Integration of PC
teams into routine
oncology care through
the co-management of
cancer diagnosis

•

Development of a
clinical care pathway
for PC that will allow
for patients to decide
if needed/wanted.

Well established free
Cancer Supportive
Care Program offered
at Stanford Health
Care

•

Coordinate PC
appointments with
other appointments so
that patients may
benefit from services
Involve PC early or
encourage providers to
ask about patient
preferences and goals
at the time of
diagnosis
Provide advanced care
planning early on in
disease trajectory
Create electronic
“triggers” to identify
patients eligible for
PC consults/ongoing
visits

•

•

Clinical Information
Systems
Using Information Systems
to proactively inform
patient care

•

Difficult to identify
patients/families in
need of a palliative
care consult

•

Well established,
high-functioning
EHR with a large
team of Information
Specialists

•
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Appendix E: Overview of Current State

Palliative Care
•" Aims)to)improve)quality)of)life)for)patients)and)families))
facing)serious)illness.)
•" It)can)help)to)relieve)pain,)symptoms)and)stress,)whatever)
the)prognosis.)
•" It’s)appropriate)at)any)age)and)at)any)stage)and)can)be))
provided)along)with)curative)treatment.)(CAPC,&ACS)

Value
Patients + Families

Clinical Care Teams

Healthcare Systems

Improved)quality)of)life
Decreased)physical)and)emotional)
symptom)burden
Longer)survivial
Improved)coordination)of)care
Decreased)unnecessary)or)unwanted)
medical)care)
Earlier)access)to)end<of<life)services
More)informed)decision<making
Enhanced)trust)in)healthcare)providers

Enhanced)communication)and))
collaboration)among)interdisciplinary)
team)members,)patients)and)family
Enhanced)provision)of)holistic,))
patient<centered)care
Better)patient)and)caregiver))
outcomes
Improved)symptom)management
Increased)patient)and)family))
satisfaction

Decreased)cost:
•" Less)ED)visits)and)admissions
•" Estimated)$1.2)billion)annual)
cost)savings)over)current)inpa<
tient)utilization
•" Decreased)length)of)stay
•" Better)utilization)of)resources
Increased)provider,)patient,)and)
family)satisfaction
Better)provision)of)evidence<based)
practice,)patient<centered)care

70%)of)Americans)are)“not)at)all)knowledgeable”)about)palliative)care.)Yet)92%))
of)people)polled)would)likely)consider)palliative)care)when)it)was)explained.&(ACS)&

Practice
All*clinicians*practice*palliative*medicine.*Specialist*teams*
are*available*to*provide*support.

Process

Staffing

Inpatient
Shift:
1)Physician
1)Adv)practice)Nn
1)Social)worker
1)Fellow

70%
of healthcare
systems have
a palliative
program

Outpatient
Total:
4)Physicians
4)APNs
Social)workers
Fellows

24/7%service
1.) Receive)consult)requests)from)primary)teams
2.) Open)the)consult)same)day)as)placed
3.) Maintain)contact)with)primary)team)while)
patient)remains)in)hospital
4.) Refer)to)outpatient)team,)as)appropriate.

Find)out)more)at)http://lane.stanford.edu/portals/palliative<care.html

Shift:
1)Physician
1)Nurse)practitioner
1)Social)worker)

Total:
3)Physicians
2)NPs
3)Social)workers
1)Chaplain
1)CAA

Standard%clinic%hours
1.) EPIC)referrals)+)“urgent”)day<of)referrals
2.) New)patient:)NPC)checks)on)insurance)and)
schedules)with)outpatient)MD/NP)team
3.) Visit:)Within)one)week)of)referral;)social)
worker)may)join)visit
4.) Ongoing:)1/week)or)1/3<month
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Barriers
1)*Process*
Theme
Palliative)overlap)with))
other)supportive)services

Representative)Quote
“I)am)confused)in)terms)of)how)to)use)these)programs.)We)have)palliative)care...pain)clin<
ic...integrative)medicine.)I)have)no)idea)which)one)to)send)to.”
“It)would)be)nice)if)that)was)all)under)one)umbrella.”))

Timing)

“The"¿rst"call"is"not"the"time"for"screening"or"referral."You"haven’t"made"a"connection"yet,"
built"rapport."You"are"trying"to"get"them"ready"for"that"¿rst"appointment.”
“I)think)it’s)pretty)variable.)In)the)past,)somebody)with)incurable)cancer,)you)can)rely)on)
their)life)expectancy)to)be)short...that’s)not)going)to)be)uniformly)true)more)and)more.”

Referral)process)is:
•" Unclear

“The)problem)is)that)some)people)just)blankly)make)referrals,)where)they)don’t)understand)
the)disease...and)that’s)generally)problematic...it’s)a)whole)bad)game)of)telephone.”)

•"

“The"logistics…took"me"¿ve"phone"calls"to"¿gure"out"who"the"new"patient"coordinator"
was…took"another"¿ve"phone"calls"to"try"and"get"the"patient"seen…I"think"just"making"the"
process)of)referring)them)easier.”

Cumbersome

Scheduling

“Going)to)another)clinic,)it’s)an)aggravation,)and)they’re)perturbed)enough.)Having)some<
one)say)it’s)available)at)the)heme)clinic)or)available)on)call)would)be)useful.”

Communication)between)
teams

“I’ve)had)some)pretty)direct)conversations)where)I)say,)“Stop)managing)them.)Are)you)
going)to)take)care)of)this)patient)or)am)I)going)to)take)care)of)this)patient)because)we)keep)
doing)this.))The)communication)isn’t)right.))It’s)getting)all)messed)up.”)

Lack)of)capacity

“I)mean)it’s)shown)by)the)lung)cancer)study)as)early)as)we)can,)but)right)now)it)just)doesn’t)
feel)like)it’s)feasible)to)call)them)for)all)of)our)newly)diagnosed)metastatic)patients.”
“Is)there)someone)on<call)that)I)can)reach)out)to?)Is)there)a)pager?)What)if)there)are)multi<
ple)cases)at)once?)Is)there)capacity)for)this?”

2)*Perception
Theme
Palliative)medicine)is)for)
end<of<life)or)when)there))
are)“no)other)options”

Representative)Quote
“That’s)the)problem)with)most)of)us.)We)call)palliative)care)when)we)have)no)other))
options)for)the)patients)but)we)don’t)call)them)early)on.”
“It’s)a)very)important)specialized)role)in)the)terminal)phase)of)disease)with)I)just)cannot)
say)...)I)cannot)do)anything)for)this)patient.”))
“Even)though)we)may)think)of)palliative)care)as)being)symptom)control)and)manage<
ment...and)addressing)symptoms)related)to)cancer,)patients)always)hear,)“Why)is)he)
bringing)them)up)palliative)care?)Am)I)going)to)die?”)It)is)challenging.”

Assumption)that)oncology)
does)not)provide)palliative

“‘Yeah,)because)I)don’t)give)any)of)my)patients)supportive)care.)I)just)give)them)chemo.’))
I)think)the)insult)that)we)all)feel)about)being)thought)of)as)either...fry)them)or)run)toxins)
through)them)but)heaven)forbid)that)I)should)actually)acknowledge)there’s)a)human)being)
within)my)bond.”

Feeling)that)separate)team)
is)not)absolutely)necessary

“I)think)that)you)don’t)need)a)dedicated)palliative)care)physician)to)provide)palliative)care)
to)your)patient)nor)should)that)imply)that)somehow)you’re)not)supposed)to)be)providing)
palliative)care)because)probably)the)majority)of)what)we)do)is)actually)palliative)care.”

Con¿dence"in"palliative"
team’s)level)of)disease<)
speci¿c"knowledge

“I’ll)think)it)will)be)more)useful)if)they,)say,)get)to)know)the)disease)a)little)better.))Like)we)
have)for)lymphoma,)half)the)patients)are)cured…”
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Appendix F: Evidence Synthesis Table of Reviewed Randomized Control Trials
Study
Authors
Bakitas et
al.

Year
Publis
hed
2009

Palliative Care
Service or
Intervention
Nurse-led
multicomponent,
psychoeducational
intervention
telephone-based
approach

Patient
Population
Male and
female
patients with
GI, Lung, GU,
and Breast
cancer

Measurement/Asses
sment Tool
•

•

•

Follwell et
al.

Temel et al.

Zimmerman
et al.

2009

2010

2014

Referral to palliative
care consultation in
outpatient setting

Male and
female
patients with
GI, Breast,
Lung, Head
and Neck,
Brain,
Gynecologic,
Skin, GU,
Hematologic,
and unknown
primary
cancers

•

Palliative care
consult with an
interdisciplinary
palliative care team,
which includes:
assessment of
physical and
psychosocial
symptoms, goals of
care, assisting with
decision making
regarding treatment,
and coordinating
care based on needs

Male and
Female
patients with
newly
diagnosed
non-small-cell
lung cancer

•

Provision of early
palliative care

A variety of
advanced

•

•

•
•

•
•

Outcomes

Functional
Assessment of
Chronic Illness
Therapy for
Palliative Care
(FACT-PC)
Edmonton
Symptom
Assessment Scale
(ESAS)
Center for
Epidemiological
Studies
Depression Scale
(CES-D)
Edmonton
Symptom
Assessment Scale
Distress Score
(EDS)
Family
Satisfaction with
Advanced Cancer
Care
(FAMCARE),
patient-adapted
version

•

Functional
Assessment of
Cancer TherapyLung (FACT-L)
Lung-cancer
subscale (LCS)
of the FACT-L
Trial Outcome
Index (TOI)
Hospital Anxiety
and Depression
Scale (HADS)
Patient Health
Questionnaire
Functional
Assessment of

•

•
•

•

•

•

•
•

•

Improvement in
quality of life
(P= 0.02)
Improvement in
mood (P= 0.02)
Improvement in
symptom burden
(P=0.06)
No statistically
significant
variation in
resource
utilization
between groups
Improvement of
EDS scores at
one week and one
week (P values
ranging from
P<0.0001- P=
0.009)
Improvement of
FAMCARE
scores at both one
and six weeks (P
values ranging
from P< 0.0001P= 0.002)
Reduction of
depressive
symptoms (P=
0.01 for HADSD; P= 0.04 for
PHQ-9)
Improved quality
of life (P= 0.03)
Clinically
significant but
not statistically
significant
improvement in
anxiety (P= .66).
At 3-months,
there was no
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versus standard
cancer care

cancer patients
with an
European
Cooperative
Oncology
Group
performance
status of 0–2,
and a clinical
prognosis of
6–24 months.

•

•
•
•

120

Chronic Illness
Therapy—
Spiritual WellBeing (FACITSp)
Quality of Life at
the End of Life
(QUAL-E)
ESAS
FAMCARE-P16
Cancer
Rehabilitation
Evaluation
System Medical
Interaction
Subscale
(CARES-MIS)
•

•

Carlson et
al.

2012

Screening with
computerized triage
or personalized
triage following
screening for
distress

Newly
•
diagnosed
cancer patients •
18yrs and
older with any •
type of cancer
•

•

Distress
Thermometer
Pain numerical
rating scale
Fatigue numeric
rating scale
Psychological
screen for cancer
using the
PSSCAN Part C
Access to
services (asked at
3,6, and
12months by a
screening
assistant)

•

•

significant
difference in
change score for
FACIT-Sp
between
intervention and
control groups;
there was a
significant
difference in
QUAL-E
(p=0.05) and
FAMCARE-P16
(p=o.0003), and
no difference in
ESAS (p=.33) or
CARES-MIS
(p=0.40).
At 4 months,
there were
significant
differences in
change scores for
all outcomes
except CARESMIS.
All differences
favored the
intervention
group.
No changes
between triage
groups in regards
to their distress,
anxiety,
depression, pain,
and/or fatigue
over the course of
the 12-month
study period
the group who
received
personalized
triage accessed
more services
than the
computerized
group (1,213
services versus
825 services).
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Glare et al.

2013

Implementing the
screening and
referral components
of the NCCN
Guidelines for
Palliative Care

Hospitalized
patients
admitted to
the
Gastrointestin
al Oncology
service

•

NCCN
Guidelines for 6
palliative care
concerns:
uncontrolled
symptoms,
moderate-tosevere distress,
serious comorbid
conditions, a poor
prognosis,
patient/family
concerns about
the course of the
disease and
treatment
decision-making,
and
patient/family
requests for PC

121
•

•
•

•

Screening was
feasible as
reported by the
nurses who
screened the
patients
Increase in access
to Palliative Care
50% of patients
with early stage
disease or no
disease screened
positive due to
comorbid illness,
poor performance
status, and/or had
uncontrolled
symptoms.
Current criteria
may be too
sensitive for the
inpatient
environment
given that 64% of
patients screened
indicated a need
for a palliative
care consult, but
30% of them
were managed by
their primary
team.
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Appendix G: Levels of Evidence Table

	
  
Level 1
Systematic
Review or
MetaAnalysis
Greer et al.
(2013)
Zimmerman et
al. (2014)
Teunissen et
al. (2007)
Follwell et al.
(2009)
Bausewein et
al. (2011)
Brasel (2007)
NIH (2004)
Richards et al.
(2011)
Browner and
Smith (2013)
Stro¨mgren et
al. (2002)
Schultheis et
al. (2013)
PelayoAlvarez et al.
(2013)
Bush et al.
(2010)
Carlson et al.
(2012)
Glare et al.
(2013)
Dudgeon et al.
(2008)
Seow et al.
(2010)
Kamal et al.
(2013)
Khatcheressian
et al. (2005)
Cleeland et al.
(2013)

122

Level 2
Randomized
Control
Trial

Level 3
Controlled
Trial
without
Randomization

Level 4
Case
control or
Cohort
study

Level 5
Systematic
Review of
Qualitative
or
Descriptive
Studies

Level 6
Qualitative
or
Descriptive
study

Level 7
Other
Expert
Review
Opinion or Article
Consensus

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
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Appendix H: IRB Exempt from USF
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Appendix I: PROMIS Tool
STANFORD HOSPITAL and CLINICS
STANFORD, CALIFORNIA 94305

Medical Record Number
Patient Name

CLINICS CANCER CENTER WELLNESS SURVEY
Page 1 of 2

Addressograph or Label - Patient Name, Medical Record Number

Taking care of your physical and emotional health is very important to us. To better address your
health needs; please respond to each item by marking one box per row. Once completed, please
give this form to a medical assistant. We will review your responses during today’s visit and together
determine the support you may want or need. If you have completed this survey in the last 30 days
and your answers have not changed, please do not ﬁll out the survey and check here. !
This survey is not a replacement for a conversation with your health care provider. If you have
concerns please contact your health care team.

Excellent

Very
Good

Good

Fair

Poor

In general, would you say your
health is….

!

!

!

!

!

5

4

3

2

1

In general, would you say your
quality of life is….

!

!

!

!

!

5

4

3

2

1

In general, how would you rate your
physical health?

!

!

!

!

!

5

4

3

2

1

In general, how would you rate your
mental health including your mood
and your ability to think?

!

!

!

!

!

5

4

3

2

1

In general, how would you rate your
satisfaction with your social activities
and relationships?

!

!

!

!

!

5

4

3

2

1

In general, please rate how well you
carry out your usual social activities
and roles.
(This includes activities at home,
at work and in your community;
responsibilities as a parent, child,
employee, friend)

!

!

!

!

!

5

4

3

2

1

© 2008-2013 PROMIS Health Organization and PROMIS Cooperative Group
15-2876 (4/13)
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STANFORD HOSPITAL and CLINICS
STANFORD, CALIFORNIA 94305

Medical Record Number
Patient Name

CLINICS CANCER CENTER WELLNESS SURVEY
Page 2 of 2

Addressograph or Label - Patient Name, Medical Record Number

Completely

Mostly

Moderately

A little

Not at all

!

!

!

!

!

5

4

3

2

1

Never

Rarely

Sometimes

Often

Always

!

!

!

!

!

1

2

3

4

5

None

Mild

Moderate

Severe

Very Severe

!

!

!

!

!

1

2

3

4

5

Not at all

A little bit

Somewhat

Quite a bit

Very
much

How true was this before
your illness?

!

!

!

!

!

1

2

3

4

5

How true is this now,
since your illness?

!

!

!

!

!

1

2

3

4

5

To what extent are you able to
carry out your everyday physical
activities such as walking,
climbing stairs, carrying groceries,
or moving a chair?
In the past 7 days…
How often have you been
bothered by emotional problems
such as feeling anxious,
depressed or irritable?

How would you rate
your fatigue?

My life lacks meaning...

How would you rate your pain on
average?

!
0

!

!

!

!

!

!

!

!

!

!

1

2

3

4

5

6

7

8

9

10

No pain

Worst imaginable pain

If you would like help with any issue noted above, please write the issue here
.

Date

Time

Signature

Relationship to Patient

(Patient, or Properly Designated Representative)

Date

Time

Staff Signature

Print Name

© 2008-2013 PROMIS Health Organization and PROMIS Cooperative Group
15-2876 (4/13)

Print Name
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Appendix J: Algorithm for Distress Management
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Appendix K: Nurse Coordinator Survey
[SURVEY PREVIEW MODE] PROMIS Survey

https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

PROMIS Survey
PROMIS Wellness Survey Feedback Questionnaire

The PROMIS Wellness Survey was launched digitally Cancer Center wide on June 8,
2015. The development team wants to make sure screening for patients’ psychosocial
needs is as efficient and as useful as possible. We need your feedback to improve the
process for screening and distress management. Please answer the questions below. It
should take less than 5 minutes to complete. Thank you!
1. As a screening tool, how effective is the PROMIS Wellness Survey in
identifying patients’ emotional, physical, and practical needs?
Not at all Effective
Somewhat Ineffective
Not Sure
Somewhat Effective
Very Effective
Comments about effectiveness:

1 of 6

10/19/15, 12:35 PM
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[SURVEY PREVIEW MODE] PROMIS Survey
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https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

2. How accurately do you feel the PROMIS Wellness Survey represents patient
emotional, physical and practical needs?
Not At All Accurately
Somewhat Inaccurately
Not sure
Somewhat Accurately
Very Accurately
Comments:

3. How helpful has the PROMIS Wellness Survey been to enabling informed
discussions with patients about their emotional, physical and practical needs?
Not at all Helpful
Somewhat Unhelpful
Not Sure
Somewhat Helpful
Very Helpful
Comments:

2 of 6

10/19/15, 12:35 PM
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[SURVEY PREVIEW MODE] PROMIS Survey
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https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

4. How often do you open PROMIS Wellness Surveys associated with your
patients?
Never
Rarely
Sometimes
Often
Always

5. How helpful has the PROMIS Wellness Survey been in decreasing barriers
to appropriate referrals to other services?
Not at all Helpful
Somewhat Helpful
Not Sure
Somewhat Helpful
Very Helpful
Comments about referrals:

3 of 6

10/19/15, 12:35 PM
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https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

6. How easy is it to navigate through EPIC to identify "unanswered
questionnaires" and facilitate patient completion of the PROMIS Wellness
Survey?
Very Difficult
Somewhat Difficult
Not Sure
Somewhat Easy
Very Easy
Please tell us why you gave this ranking:

7. How easy is it to navigate through EPIC to access the PROMIS Wellness Survey
responses?
Very Difficult
Somewhat Difficult
Not Sure
Somewhat Easy
Very Easy
Please tell us why you gave this rating:

4 of 6

10/19/15, 12:35 PM
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https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

8. How clear are the steps for following up on a need identified through the
PROMIS Wellness Survey?
Not at all Clear
Somewhat Unclear
Neutral
Somewhat Clear
Very Clear
Comments about follow-up to patient responses:

9. How adequate was the training you received in enabling you to utilize the
PROMIS Wellness Survey and access resources to meet patients' emotional,
physical and practical needs?
Not at all Adequate
Somewhat Inadequate
Not Sure
Somewhat Adequate
Very Adequate
Comments about training:

5 of 6

10/19/15, 12:35 PM
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https://www.surveymonkey.com/r/?sm=UgXtLpRrzpNfv5pNt...

10. From the list below, please indicate if any of the following (you may select
more than one) are outcomes you expect to find as a result of the PROMIS
Wellness Survey?
Improved patient psychosocial outcomes
Improved physical symptom management
Better understanding of patient needs
Improved communication with patients
Improved coordination of care between oncology and specialist services
More efficient visits
Greater patient satisfaction
Greater staff satisfaction
More structured workflow around managing patient care needs
Other (please specify)

Powered by

See how easy it is to create a survey.

6 of 6

10/19/15, 12:35 PM
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Appendix L: Survey for Medical Assistants
[SURVEY PREVIEW MODE] PROMIS Survey - MA Staff

https://www.surveymonkey.com/r/?sm=eDMkxyChBVnTLyO...

PROMIS Survey - MA Staff
PROMIS Wellness Survey Feedback Questionnaire

The PROMIS Wellness Survey was launched digitally Cancer Center wide on June 8,
2015. The development team wants to make sure screening for patients’ psychosocial
needs is as efficient and as useful as possible. We need your feedback to improve the
process for screening and distress management. Please answer the questions below.
All answers are anonymous. It should take less than 5 minutes to complete. Thank
you!
1. How easy is it to identify "unanswered questionnaires" in EPIC?
Very Difficult
Somewhat Difficult
Not Sure
Somewhat Easy
Very Easy
Please tell us why you gave this ranking:

1 of 4

10/19/15, 12:43 PM
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https://www.surveymonkey.com/r/?sm=eDMkxyChBVnTLyO...

2. How easy is it to help patients complete the PROMIS Wellness Survey in EPIC?
Very Difficult
Somewhat Difficult
Not Sure
Somewhat Easy
Very Easy
Please tell us why you gave this ranking:

3. How easy is it to view the PROMIS Wellness Survey responses in EPIC once a
survey has been completed?
Very Difficult
Somewhat Difficult
Not Sure
Somewhat Easy
Very Easy
Please tell us why you gave this rating:

2 of 4

10/19/15, 12:43 PM
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https://www.surveymonkey.com/r/?sm=eDMkxyChBVnTLyO...

4. How clear are the steps for following up on a need identified through the
PROMIS Wellness Survey?
Very Unclear
Somewhat Unclear
Not Sure
Somewhat Clear
Very Clear
Comments about follow-up to patient responses:

5. How helpful was the training you received in showing you how to access
the PROMIS Wellness Survey and escalate needs to other members of the clinical
team?
Very Inadequate
Somewhat Inadequate
Not Sure
Somewhat Adequate
Very Adequate
Comments about training:

Powered by

3 of 4

10/19/15, 12:43 PM
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Appendix M: One-Page PROMIS Pamphlet—For Staff

PROMIS%Wellness%Survey:%The&Basics
What%is%PROMIS?
PROMIS&is&a&validated&screening&tool&developed&and&tested&by&the&National&Institutes&of&
Health&(NIH)&to&report&on&physical,&emotional&and&social&wellbeing.
PROMIS&is&a&starting&point&for&conversations&about&what&patients&are&able&to&do&and&
how&they&feel.&The&tool&provides&a&standard&way&to&collect&information&about&patient&
needs&and&health&outcomes&and&track&them&over&time.

Benefits%of%PROMIS
!
!
!
!
!

Early&identification&of&patients&at&risk&for&significant&distress&
Ability&to&better&identify&and&alleviate&physical,&emotional,&and&social&distress&for&
patients,&in&general.
Ability&to&better&identify&appropriate&referrals&to&specialty&services
Improved&physical,&social&and&emotional&outcomes
Improved&ability&to&provide&patientLcentered&care

Steps%to%Access%and%Document%PROMIS
1. From&the&Clinic&Schedule,&add&“Wellness&Survey”&to&the&toolbar.&Select&
patient&to&review&responses.
2. Share&information&with&others&on&the&care&team.
3. Talk&with&patients&about&PROMIS&responses&to&assess&needs.&In&the&case&
of&severe&distress,&consider&referral&to&palliative&medicine.
4. Use&the&dot&phrase&“.PROMISEQNR”&to&pull&survey&results&into&visit&note&
and&comment&on&outcomes&and&care&plan.&
What%are%the%guidelines%and%evidence%behind%standard%screening%for%symptoms?
!
!

Early&screening&and&management&of&symptoms&and&distress&has&been&shown&to&
improve&patient&quality&of&life,&coping,&and&decisionLmaking.
The&Quality&Oncology&Practice&Initiative&(QOPI)&through&the&American&Society&of&
Clinical&Oncology&requires&all&cancer&patients&be&screened&for&wellness&by&their&
second&physician&visit.&Screening&and&addressing&holistic&needs&early&and&
regularly&during&treatment&is&one&way&Stanford&is&providing&quality&patientL
centered&cancer&care.&

Questions%or%concerns:%Contact&LaTisha&Webster&at&(650)&498L1743&or&
LWebster@stanfordhealthcare.org.&Access&EpiCenter&for&additional&instructions.

Draft&6.3.15&ET
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Appendix N: Gantt Chart

Workplan & Timeline
Project Approval
User engagement
Convene group of clinical, operational, and research
staff for development
Development/Planning
Tool Selection
POS Selection
POS pilot project
POS pilot project evaluation
PROMIS tool selection
PROMIS intervention planning
Design Workshop
Algorithm and care pathways
Assessment of internal supportive resources
Lit. review of existing screening tools & processes
Draft and vet algorithm w/ multi-disciplinary team
EPIC/IT infrastructure
Map overlapping services
Review summaries with patient/family
Refine summaries
Operational support
Appoint Administrative lead
Assign and train triage staff
Create algorithm for symptom-based referral
Develop interface for referring providers
Evaluation plan
Ongoing PDSA
RN/NC/MA survey development
RN/NC/MA survey distribution
Education and Training
Initial training
Orientation and initial training - RN staff
Orientation and initial training - MA staff
On-site "shoulder" support - first week of launch
Attend RN and MA morning huddles
One-pager summaries, tip sheets and cards
Ongoing training and engagement
Monthly trainings - RN staff
Monthly trainings - MA staff
Daily emails identifying patients w/ indicated needs
Presentations at physician leadership meetings
Feedback acquisition (both formally and
informally)
PROMIS launch
Implementation
PDSA
Electronic Reporting Functionality

2015

Jan
Feb
Mar
Apr
May
June
July
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
June
July
Aug
Sep
Oct
Nov
Dec

2014
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Appendix O: Communication Matrix

Vice%
President%
of%SCI%

Chief%
Medical%
Director%

Dr.%
Ramchandran%

PROMIS%
Design%Team%

Director%of%
SCI%
Opera;ons%
ICCP%
Opera;ons%
Manager%

EPIC%

Director%of%Pa;ent%
Quality%and%Safety%

Senior%Program%
Manager%of%
Transforma;ons%
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Appendix P: Percent of Patients with Relevant Answers
(8/17/2015-9/30/2015)
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Appendix Q: Cost/Benefit Analysis
Annual Expense Report
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Annual Income Report

Return On Investment (ROI)= $119,040/$234,087= 0.508 or 51%.

145
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Appendix R: Breakeven Analysis
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Appendix S: Nurse Coordinator Workflow
PROMIS'Wellness'Survey'
Work%flow%and%algorithm%(draft)
Overview
Purpose
Cancer%and%its%treatment%impacts%the%physical,%emotional,%social,%and%spiritual%wellness%in%
individuals%and%families%experiencing%cancer.%Symptoms%and%distress%can%be%complex,%pervasive%
and%change%dramatically%over%time.%Screening%and%addressing%these%concerns%early%and%regularly%
during%treatment%at%Stanford%Cancer%Center%can%help%alleviate%distress%and%promote%wellness.%
Establishing%an%empathic%and%routine%assessment%of%these%needs%may%promote%more%meaningful%
conversations%between%patients%and%their%care%teams%about%individual%needs%and%goals.%
Owners
'''Distribution

MyHealth:%EPIC%trigger
Clinic:%MA

'''Collection

MA

'''Assessment

MCC/NC
Psychosocial%needs:
First&line%–%service%line%social%work;%
Additional&specialist%–%Palliative%Medicine%(June%2015);%LiveWell%(future)

'''Management
Physical%needs:
First&line%–%service%line%APP/MD%
Specialist%–%PM%(June%2015);%LiveWell(future)
'''Reporting

LiveWell

Timing
'''Initial

First%return%visit

'''Follow@up

Once%every%3%months

Setting
InXperson%assessment
Dedicated%space
Dedicated%time
Assumptions
!
!
!
!
!
!
!
!
!

Results%are%easily%visible%
Administrative%“cell”%relieves%tasks/time%if%owner%is%MCC/NC
Dedicated%space
Dedicated%time%(2nd%visit%and%followXup)
Effective%communication%between%provider%and%patient/family
Referral%and%recommendation%respected%by%APPs
Social%work%has%capacity%to%act%as%first%line%response%for%psychosocial%needs
Wellness%is%a%quality%measure
Others…

Updated%7.6.15

1
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PROMIS'Wellness'Survey'
Work%flow%and%algorithm%(draft)
Procedure'Overview
1.
2.
3.
4.
5.

Patient%completes%survey%independently%(initial%survey%completed%with%provider).
MCC/NC%determines%areas%for%followXup%assessment.
Provider%assesses%need%and%classifies%patient%distress%level.
Provider%discusses%physical%and%psychosocial%support%options%with%patient%and%family.
Provider%makes%call%or%referral%to:
o Psychosocial
! Service%line%social%work
! PM/LiveWell
o Physical&
! Service%line%APP
! PM/LiveWell
6. Provider%documents%completion%of%assessment%and%specific%followXup%note.
7. FollowXup%with%patient%within%XX%timeframe.

Updated%7.6.15

2
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Appendix T: Anticipated Outcomes Table
[Paper] Section
Anticipated Outcome

Measure
Improved coordination of care

Comments
Not easily measurable. Moderating variable to
end goals. See end goals.

Anticipated Outcome

Enhanced ability of patients/families
to identify and express care needs

Not easily measurable. Moderating variable to
end goals. See end goals.

Anticipated Outcome

Normalization of asking about patient
well being [for clinicians]

Not easily measurable. Moderating variable to
end goals. See end goals.

Anticipated Outcome

Enchanced attention to well-being
during clinic visits and incorporation
into treatment plans
More appropriate and timely access to
supportive care services

Not easily measurable. Moderating variable to
end goals. See end goals.

Anticipated Outcome

Not easily measurable. Moderating variable to
end goals. See end goals. See also Metric
"…referred to supportive care services."
Not easily measurable. Moderating variable to
end goals. See end goals. See also
Administrative/Program Development costs.

Anticipated Outcome

Standardized procedures and
protocols for identification of patients
in distress, referral criteria, and
follow-up documentation

Anticipated Outcome

Increased referrals to supportive
services
Standardized roles and trained
personnel who hold referral
responsibility
Every cancer patient screened by
second visit with PROMIS

See Metric "…referred to supportive care
services."
See Administrative/Program Development
costs.

Ensure patients with supportive care
needs (relevant answers) are
addressed and/or referred
Number of patients who receive a
PROMIS questionnaire

See Metric "…addressed by their oncology
team." and "…referred to supportive care
services."
No cost or benefit to this metric. PROMIS is
patient self-administered. Cost was on
development of tool and is captured in
Administrative/Program Development costs.
Anticipated benefit is articulated in End Goals.
No cost or benefit to this metric. PROMIS is
patient self-administered. Cost was on
development of tool and is captured in
Administrative/Program Development costs.
Anticipated benefit is articulated in End Goals.
Identification of needs requires manual review
by RN of completed PROMIS tool and
subsequent follow-up and management. This is
a cost.

Anticipated Outcome

Aim

Performance Goal

Metrics

Metrics

Number of patients who complete a
PROMIS questionnaire

Metrics

Number of patients with identified
needs

See Metric "Number of patients who receive a
PROMIS questionnaire."
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Metrics

Number of patients with identified
needs addressed by their oncology
team

No cost or benefit to this metric. Addressing
identified needs is included in a standard
reimbursable evaluation and management
encounter and does not require additional nonreimbursable services. Benefit: Addressing
identified needs is a moderating variable to end
goals. See end goals.

Metrics

Number of patients with identified
needs referred to supportive care
services

No cost or benefit to this metric. Referring to
supportive care services is included in a
standard reimbursable evaluation and
management encounter and does not require
additional non-reimbursable services. Benefit:
Referring to supportive care services is a
moderating variable to end goals. See end
goals.

Metrics

Number of patients with identified
needs seen by the referred party

No cost or benefit to this metric. Seeing the
patient is included in a standard reimbursable
evaluation and management encounter and does
not require additional non-reimbursable
services. Benefit: Seeing the patient is a
moderating variable to end goals. See end
goals.

Metrics

[Survey] Number of patients who
report that their care team asked about
their physical, spiritual, emotional and
social needs
[Survey] Number of patients who
report that their treatment plan
considered those needs
[Survey] Number of patients who
report that their care team discussed
with them how cancer and treatment
would impact daily activities

Metrics

Metrics

Metrics

End Goal

[Survey] Number of patients who
report that their care team delivered
whole person care
Improvement in symptoms and
psychosocial health
Decrease ED visits

End Goal

Decrease inpatient admissions

End Goal

The End Goal metric costs are unknown to this
author. However, given that SHC is a tertiary
care facility whos revenue is based in the
provision of reimbursable services, any metric
which aims to reduce the provision of such
services results in a net cost to SHC. Despite
the loss to SHC, all other stakeholders (e.g.,
consumers, payors/insurers, tax payers [funding
state/federal health care programs], etc) benefit
from the any attainment of this goal.
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STRENGTHS
•
•
•
•

•
•
•
•

•
•

Appendix U: SWOT Analysis

No selection bias
No additional expenses
Provides more appropriate, timely access to
supportive care services
In accordance with QOPI guidelines and other
national organization recommendations (ASCO,
CAPC, NCCN, NIH)
Supportive care services already in place
Exemplifies an integrative model of palliative
care and oncology care
Fosters active patient and family participation in
plan of care
PRO screening aids in more efficieient
monitoring of patient symptoms and treatment
response over time
Proactive patient care planning
Better utilization of resources

WEAKNESSES
•
•
•
•
•
•
•
•
•
•
•

•

OPPORTUNITIES
•
•
•
•

•
•
•
•
•
•
•
•
•
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To identify and address comprehensive care
needs early
To use electronic clinical decision making tools
to enhance patient care
Improved coordination of care; defragment care
To provide information of impact of PROS on
QI, transparency, accountability, public
reporting, improved system performances, and
impact on health outcomes
Enhance rapport and communication between
patients/families and clinicians
Improved symptom management
Improved QOL
Change in culture and perceptions around
palliative care and psychosocial health
Integration of palliative care into routine
oncology clinical practice
More informed decision making
Standardized assessment tool
Decrease ED visits and hospital admissions
Better allocation of resources	
  
	
  

Many clinicians do not feel prepared to address
supportive care needs or psychosocial issues
Time constraints; charting responsibilities;
patient volume
Busy work environment
No standardized referral algorithm in place
Clinician bias blocking screening and/or referral
Only administered in English
Unable to pilot project prior to implementation
Supportive care services already in place
Exemplifies an integrative model of palliative
care and oncology care
Fosters active patient and family participation in
plan of care
PRO screening aids in more efficient monitoring
of patient symptoms and treatment response over
time
Proactive	
  patient	
  care	
  planning	
  

THREATS
•
•
•
•
•

•
•
•
•
•

Limited training in how to ask and respond to
questions about distress
Lack of clinician engagement
Patient and clinicians negative perceptions of the
usefulness of screening
Misconceptions and misunderstanding of
palliative and supportive care
Patients with low literacy, language barriers,
visual or physical impairments are more difficult
to engage via screening
Time/Workload
Role definition
Fear and anxiety
Stakeholder buy-in
Underdeveloped operational infrastructure
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Question 1

Appendix V: Breakdown of Nurse Responses by Question
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Question 7
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Question 8
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Question 9
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Appendix W: Completion Rates for PROMIS by CCP from April-September 2015

Disease	
  Group	
  
BMT	
  
Breast	
  
Cutaneous	
  
Gastrointestinal	
  
Gynecology	
  
Head/Neck	
  
Hematology	
  
Lymphoma	
  
Neurology	
  
Radiation	
  Oncology	
  
Sarcoma	
  
Skin	
  Cancer	
  &	
  Melanoma	
  
Thoracic	
  
Urology	
  

April	
  
N/A	
  
37.3%	
  
N/A	
  
N/A	
  
26.0%	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  

May	
  
N/A	
  
12.5%	
  
N/A	
  
N/A	
  
10.3%	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  
N/A	
  

June	
  
9.1%	
  
5.6%	
  
15.0%	
  
9.8%	
  
4.7%	
  
38.9%	
  
12.3%	
  
4.0%	
  
16.1%	
  
7.3%	
  
0.0%	
  
24.5%	
  
6.0%	
  
3.5%	
  

July	
  
5.7%	
  
8.8%	
  
0.0%	
  
4.4%	
  
17.5%	
  
9.9%	
  
5.3%	
  
6.6%	
  
2.7%	
  
7.8%	
  
0.0%	
  
2.8%	
  
3.1%	
  
14.8%	
  

August	
  
5.6%	
  
7.8%	
  
20.0%	
  
4.7%	
  
13.2%	
  
18.2%	
  
9.0%	
  
5.1%	
  
3.3%	
  
5.4%	
  
0.0%	
  
11.7%	
  
5.9%	
  
34.2%	
  

September	
  
3.7%	
  
17.1%	
  
32.6%	
  
3.7%	
  
16.9%	
  
41.4%	
  
3.7%	
  
4.1%	
  
2.9%	
  
6.9%	
  
0.0%	
  
31.7%	
  
4.1%	
  
21.5%	
  

Total	
  
5.8%	
  
15.5%	
  
16.0%	
  
5.3%	
  
14.6%	
  
25.3%	
  
8.0%	
  
4.0%	
  
6.0%	
  
6.9%	
  
0.0%	
  
16.8%	
  
4.6%	
  
19.2%	
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Appendix X: Crisis Management for MAs

	
  

STANFORD)HOSPITAL)and)CLINICS
STANFORD,)CALIFORNIA)94305

Medical)Record)Number
Patient)Name

CLINICS)CANCER)CENTER)WELLNESS)SURVEY
Page)1)of)2

Addressograph(or(Label(#(Patient(Name,(Medical(Record(Number

Taking(care(of(your(physical(and(emotional(health(is(very(important(to(us.(To(better(address(your(
health(needs;(please(respond(to(each(item(by(marking(one(box(per(row.((Once(completed,(please(
give(this(form(to(a(medical(assistant.(We(will(review(your(responses(during(today’s(visit(and(together(
determine(the(support(you(may(want(or(need.((If(you(have(completed(this(survey(in(the(last(30(days(
and(your(answers(have(not(changed,(please(do(not(ﬁ(ll(out(the(survey(and(check(here.())អ
This(survey(is(not(a(replacement(for(a(conversation(with(your(health(care(provider.((If(you(have(
concerns(please(contact(your(health(care(team.))

Excellent

Very
Good

In(general,(would(you(say(your(
health(is….

អ

5

អ

4

In(general,(would(you(say(your(
quality(of(life(is….

អ

5

In(general,(how(would(you(rate(your(
physical(health?

Fair

Poor

អ

3

អ

2

អ

អ

4

អ

3

អ

2

អ

អ

5

អ

4

អ

3

អ

2

អ

In(general,(how(would(you(rate(your(
mental(health(including(your(mood(
and(your(ability(to(think?

អ

5

អ

4

អ

3

អ

2

អ

In(general,(how(would(you(rate(your(
satisfaction(with(your(social(activities(
and(relationships?

អ

5

អ

4

អ

3

អ

2

អ

In(general,(please(rate(how(well(you(
carry(out(your(usual(social(activities(
and(roles.((
(This(includes(activities(at(home,(
at(work(and(in(your(community;(
responsibilities(as(a(parent,(child,(
employee,(friend)

អ

អ

អ

អ

អ

5

4

©(2008#2013(PROMIS(Health(Organization(and(PROMIS(Cooperative(Group
15#2876((4/13)

Good)

3

2

1

1

1

1

1

1
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STANFORD)HOSPITAL)and)CLINICS
STANFORD,)CALIFORNIA)94305

Medical)Record)Number
Patient)Name

CLINICS)CANCER)CENTER)WELLNESS)SURVEY
Page)2)of)2

Addressograph(or(Label(#(Patient(Name,(Medical(Record(Number

Completely

Mostly

Moderately

A)little

Not)at)all

អ

5

អ

4

អ

3

អ

2

អ

Never

Rarely

Sometimes

Often

Always

អ

1

អ

2

អ

3

អ

4

អ

None

Mild

Moderate

Severe

Very)Severe

អ

1

អ

2

អ

អ

អ

Not)at)all

A)little)bit

Somewhat

Quite)a)bit

Very)
much

How(true(was(this(before
your(illness?
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អ
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អ
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អ

How(true(is(this(now,(
since(your(illness?

អ

អ

អ

អ

អ

To(what(extent(are(you(able(to(
carry(out(your(everyday(physical(
activities(such(as(walking,(
climbing(stairs,(carrying(groceries,(
or(moving(a(chair?
In#the#past#7#days…
How(often(have(you(been(
bothered(by(emotional(problems(
such(as(feeling(anxious,(
depressed(or(irritable?

How(would(you(rate
your(fatigue?

((((((((((((((((((((((((

3

1

5

4
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My(life(lacks(meaning...

How(would(you(rate(your(pain(on(
average?(
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No&pain
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អ
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អ
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Worst&imaginable&pain

If(you(would(like(help(with(any(issue(noted(above,(please(write(the(issue(here((
(

.

(
Date(
(

(((
((Time(
(

(
Date(

(((
((Time(

(((
((
((Signature(
Relationship(to(Patient(
(((Patient,(or(Properly(Designated(Representative)
(((
((Staff(Signature(

((
Print(Name

(((
((Print(Name(

©(2008#2013(PROMIS(Health(Organization(and(PROMIS(Cooperative(Group
15#2876((4/13)

*If any of the highlighted sections are marked by the patient, notify the NC, APP, or
physician (depending on your clinic reporting structure) immediately for further attention.
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Appendix Y: NC Tip Sheet for Difficult Conversations
PROMIS'Wellness'Survey'
Discussing'Psychosocial'Issues''
'

Summary'of'Tips'for'Discussing'Psychosocial'Issues'

(Developed'by'Nurse'Coordinator'Staff)'
'
'
Preparing'for'the'Discussion'
•

Make'a'list'of'items'you'hope'to'discuss.'

•

Minimize'interruptions.'

•

Take'a'deep'breath,'check'in'with'your'emotions,'and'prepare'yourself.'

•

Sit'faceMtoMface'with'the'patient'with'an'open,'relaxed'posture.'

• Remind'yourself'to'slow'down.'
'
'
Words'That'Work'
'
Ask'Permission'

•

Would'you'like'to'talk'about'this?'

Acknowledge'&'Normalize'

•
•

I'can'see'that'this'is'upsetting'to'you.'
It’s'okay/understandable'that'you'would'feel'this'way.'

•
•
•
•
•

Have'you'had'thoughts'of'suicide/ending'your'life?'
Could'you'tell'me'more'about'why'you'feel'this'way?'
How'long'have'you'felt'this'way?'
Have'you'noticed'anything'has'changed'in'the'recent'past?'
Who/what'do'you'turn'to'for'support'(e.g.'family,'faith)?'

•

Summarize'your'next'steps'before'leaving'the'patient'(e.g.,'
social'work'colleague'will'call'you'in'the'next'48'hours)'

Assess'Patient'Needs'

Close'the'Conversation'
'
'
'
'
'
'
'
'
'
'

7.14.15'ET'
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Appendix Z: One-Page PROMIS Pamphlet- For Patients

About%the%Wellness%Survey%
What%is%the%Wellness%Survey?
The$Wellness$Survey$is$a$way$for$you$to$tell$us$how$you$are$doing$with$regards$to$your$
emotional,$physical,$and$spiritual$wellbeing.$We$will$ask$you$to$answer$this$
questionnaire$periodically$so$that$we$can$bring$your$needs$into$your$plan$of$care$as$they$
change$over$time.$

Why%is%the%Wellness%Survey%important?
This$questionnaire$will$help$us$improve$your$symptoms$and$support$your$quality$of$life.$
Your$responses$will$help$identify$and$connect$you$with$resources$at$Stanford$Health$
Care$that$may$best$meet$your$needs.

What%to%Expect?
Prior%to%appointment
!
!

If$you$are$a$MyHealth$user,$you$will$receive$the$“Wellness$Survey”$three$days$
before$your$appointment.$Please$complete$the$survey$before$you$arrive$for$your$
appointment.
Once$you$have$finished$filling$out$your$questionnaire,$your$care$team$will$be$able$
to$look$at$your$results$and$use$them$to$help$you$during$your$appointment.

During%your%appointment
!
!
!

If$you$are$not$a$MyHealth$user,$your$medical$assistant$will$help$you$access$and$
complete$the$“Wellness$Survey”.
Your$nurse$or$doctor$will$use$your$responses$to$talk$with$you$about$how$we$can$
help$you$feel$as$good$as$possible$living$with$your$diagnosis.
You$and$your$nurse$or$doctor$will$create$a$plan$that$helps$you$get$the$support$
you$need.$

After%your%appointment
!
!

If$you$and$your$nurse$or$doctor$decide$it$is$appropriate,$we$will$call$you$to$
schedule$time$to$followGup$on$your$plan.
Periodically,$we$will$ask$you$to$complete$the$same$survey$so$we$can$make$sure$
that$your$changing$needs$are$a$part$of$your$plan.$

At%any%point,%please%feel%free%to%talk%with%your%nurse%or%doctor%about%health%
concerns%or%needs%you%have%that%impact%your%day>to>day%life.
Questions%or%comments%about%the%Wellness%Survey:%Contact$LaTisha$Webster$at$
(650)$498G1743$or$LWebster@stanfordhealthcare.org.$
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